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Coffee consumption is associated with reduced risk of metabolic syndrome, obesity and 
diabetes. Although the mechanisms of action are not yet elucidated, the effects of coffee 
and its bioactive components on lipid metabolism may account for the overall coffee 
effects on human health. Therefore, this study investigated the molecular mechanisms of 
coffee and its bioactive components on lipid metabolism using Caenorhabditis elegans as 
a model system. Green coffee bean extract (GCBE), the chlorogenic acid 5-O-
caffeyolquinic acid (5-CQA), and the coffee diterpenes cafestol and kahweol reduced fat 
accumulation via distinct lipid metabolism pathways and/or behavior changes in C. 
elegans. The fat-lowering effects of GCBE and 5-CQA were similarly dependent on 
sterol regulatory element binding protein (sbp-1) and forkhead box O (daf-16), both 
involved in lipogenesis, while cafestol reduced fat accumulation dependent on the FXR 
homolog, daf-12, in C. elegans. Moreover, cafestol increased worm’s moving speed, an 
vi 
 
indicator of energy expenditure. The effects of cafestol on energy expenditure was also 
dependent on tub-1 (homolog of the human TUBBY proteins), which it is likely to be a 
downstream target for DAF-12 in C. elegans. The other coffee diterpene, kahweol, also 
reduced fat accumulation, but instead kahweol’s fat-lowering effects were related to a 
reduced food intake in C. elegans. The effects of kahweol on lipid metabolism involved 
the downregulation of the insulin-like receptor daf-2, known to be regulated by food 
intake. Therefore, the suggested mechanisms of the effects of coffee bioactives on lipid 
metabolism may be applied for human health corroborating with the fact that 
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Coffee consumption is associated with reduced risk of metabolic syndrome, 
obesity and diabetes, which may be related to the effects of coffee and its bioactive 
components on lipid metabolism [1, 2]. Green coffee bean extract (GCBE) is 
commercially available as dietary supplement for weight loss even though its claims are 
not yet approved by FDA. GCBE’s fat-lowering effects are associated with chlorogenic 
acids, however other coffee components may influence the effects of GCBE on lipid 
metabolism [3]. In addition, coffee contains diterpenes (cafestol and kahweol) and 
caffeine, which it is the most studied and a known neuromodulator as adenosine receptor 
antagonist [4].  
There are evidences that lipid metabolism-related transcription factors (e.g. 
peroxisome proliferator-activated receptors and sterol regulatory element binding 
proteins) and enzymes (e.g. AMP-activated protein kinase) are regulated by coffee and/or 
its bioactive compounds, which suggest that coffee regulates lipogenesis, lipid uptake, 
transport, fatty acid β-oxidation and lipolysis [2]. However, there are still inconsistent 
reports about the effects of coffee and/or its compounds on lipid metabolism [2, 3], then 
identifying the underlying mechanisms of actions of coffee and its compounds can be 








LITERATURE REVIEW  
2.1 Introduction 
Coffee is an ancient drink that is increasingly popular around the world. People 
who drink coffee are not only attracted to its flavor, but also to its potential health 
benefits, including lower risk of metabolic syndrome, obesity and diabetes [1, 2, 4]. As 
altered lipid metabolism is common to these conditions, the effects of coffee bioactives 
on lipid metabolism have been suggested as underlying mechanisms of the health benefits 
of coffee [1, 2]. Therefore, this review primarily discusses the current knowledge of 
coffee and its bioactive components on lipid metabolism. 
2.2 Coffee composition 
The composition of regular coffee varies mostly according to type of beans, 
roasting and brewing methods [5, 6]. The most popular coffee beans are from Coffeea 
arabica (Arabica) or C. canephora (Robusta) with significant differences in their 
composition, including caffeine content; e.g. drinks from Robusta beans had higher 
caffeine levels than Arabica [5]. Roasting coffee beans degrades heat unstable 
compounds (e.g. phenolic acids and trigonelline) and changes their sensory profile [4]. 
For instance, light or medium roast coffee beans are used to make coffee drinks with 
more chlorogenic acids (CGA) than dark roast coffee beans [5]. Brewing methods 
influence the coffee drink composition as well; Turkish-style coffee drink had higher 
concentrations of diterpenes (cafestol and kahweol) than filtered coffee drink [7]. These 
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differences in composition have shown to influence the potential biological properties of 
coffee [6]. 
The most common coffee extraction is performed by hot water from beans, but 
other plant parts or solvents are used to develop other coffee products. Water extraction 
from the coffee fruit (pulp) or silver skin (bean testa), usually discarded in the regular 
coffee production, retained some of the coffee bioactive compounds, containing about 
1% CGA and 1-3% caffeine [8–10]. Different solvent extraction methods change the 
coffee extract composition. Decaffeinated coffee, which has 2-15 mg caffeine per 
serving, can be produced by organic solvents or supercritical CO2 methods [4, 11]. 
Ethanol extraction is used to make the commercially available green coffee bean extracts 
(GCBE), which contain 27-50% CGA and 2-10% caffeine [12–14]. Taken together, 
coffee processing methods have a great impact on its composition and related biological 
properties. 
2.3 Coffee bioactive compounds 
Caffeine (Fig. 2.1), an alkaloid that has a variety of potential biological effects, is 
found at concentration between 50-380 mg/100 mL in regular coffee drink [1, 4]. 
Caffeine is an adenosine receptor antagonist, related to its mostly known function as a 
neuromodulator, that boosts energy expenditure [15, 16]. Although caffeine has some 
benefits, some people need to control caffeine intake due to potential adverse effects, 
such as increased blood pressure [1].  
There are different CGA esters in coffee and their concentrations combined range 
from 35-500 mg/100 mL in the regular coffee drink [4]. CGA esters are formed between 
cinnamic acids (caffeic acid, ferulic acid, p-coumaric acid) and quinic acid; here, any 
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CGA ester is mentioned as CGA [17]. Among them, 5-O-caffeyolquinic acid (Fig. 2.1) is 
the most studied CGA ester and is linked to the GCBE’s effects [3]. In addition, the CGA 
precursors or its degraded products were related to antioxidant properties [18–20].  
 
Figure 2.1 Illustrative summary of the overall effects of coffee and its bioactive 
compounds on lipid metabolism. Molecular structures of chlorogenic acids (phenolic 
acids) representative: 5-O-caffeoylquinic acid; alkaloids: caffeine and trigonelline; 
diterpenes: cafestol and kahweol. ↓, decrease; ?, inconclusive; ↑, increase.  
 
Trigonelline (Fig. 2.1), an alkaloid derivative of niacin (vitamin B3), is present at 
40-50 mg/100 mL in regular coffee drink [4]. Although limited, trigonelline has shown 
potential biological effects, such as antioxidant and anti-inflammatory effects [21]. 
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Additionally, trigonelline has shown to be potential anti-diabetes and anti-obesity agent, 
which may also be linked to niacin’s effects on lipid metabolism [22–24].  
Cafestol (Fig. 2.1) is one of the coffee diterpenes found at 0.25-0.3 mg/100 mL in 
the regular coffee drink, and up to 4 mg/100 mL in unfiltered coffee drink [7]. High 
amounts of cafestol intake increased blood cholesterol levels; daily intake of 60 mg 
cafestol increased about 30 mg/dL total cholesterol levels in humans after 28 days [25]. 
Cafestol is an agonist of farnesoid X receptors (FXR), partially responsible for the 
increase of blood cholesterol levels by inhibiting bile acid synthesis [26, 27]. On the other 
hand, cafestol has shown beneficial biological effects, such as anti-obesity, anti-diabetes, 
anticancer and anti-inflammatory properties [28–32].  
Kahweol (Fig. 2.1), present at range of 0.14-0.2 mg/100 mL in the regular coffee 
drink, is another diterpene mostly found in Arabica coffee beans [4, 7]. In vitro studies 
have shown that kahweol is a potential antioxidant, anti-obesity and anticancer agent 
[33–35]. Although kahweol and cafestol are structurally similar, their effects on lipid 
metabolism have been shown to be different; cafestol was more effective as cholesterol-
raising factor, while kahweol was more effective as an adipogenesis inhibitor [25, 33].  
2.4 Coffee regulates lipid metabolism 
2.4.1 Coffee and human health 
Human studies have shown that moderate consumption of coffee (2-3 cups/day) is 
associated with reduced risk of metabolic syndrome, obesity and type 2 diabetes [1, 2]. 
Daily consumption of coffee (510 mg CGA and 120 mg caffeine) or GCBE (372 mg 
CGA and 14.48 mg caffeine) ameliorated some parameters for metabolic syndrome after 
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8 weeks, including reduced body fat and insulin resistance [36, 37]. Consistently, daily 
intake of 600 mg CGA increased fat oxidation in healthy male subjects after 5 days [38].  
The effects of coffee are influenced by genetic differences in the population; i.e., 
rate of caffeine metabolism contributed significantly to physiological responses to coffee 
[39, 40]. Daily intake of coffee (174.4 mg CGA and 175.2 mg caffeine) reduced 
postprandial glucose levels in people who metabolizes caffeine slowly, but increased 
postprandial glucose levels in people who metabolize caffeine quickly after 12 weeks 
[39]. However, a follow-up study reported that hypertensive patients who metabolize 
caffeine slowly had higher risk of impaired fasting glucose, compared to whom 
metabolize caffeine quickly or non-coffee drinkers [40].  
A systematic review of clinical trials has discussed inconsistent results of different 
types of coffee on glucose metabolism and suggested that CGA and other compounds 
than caffeine within coffee contribute to the coffee’s effects on human health [41]. For 
instance, a cross-over study showed that decaffeinated coffee (equivalent to 17-24 mg 
caffeine or 0.24-0.33 mg caffeine/kg body weight), but not caffeinated coffee (equivalent 
to 101-144 mg caffeine or 1.4-2.0 mg caffeine/kg body weight), improved insulin 
sensitivity in healthy men [42]. Therefore, many of the inconsistent effects of coffee on 
human health may be due to variation of coffee composition. 
Although some epidemiological studies show that moderate coffee consumption is 
associated with reduced risk of cardiovascular diseases, whether coffee has adverse or 
beneficial effects on blood lipids profile and its mechanisms is still being investigated 
[43–45]. A meta-analysis showed that coffee consumption (2.4-8 cups/day) increased 
total cholesterol, low-density lipoproteins (LDL) and triglycerides levels after 2-11 weeks 
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[1]. Others have shown that coffee has a null or beneficial effect on lipid profile; coffee 
or GCBE did not have an impact on lipid profile in healthy subjects [37, 39], while coffee 
reduced blood triglycerides levels in subjects with high cholesterol levels after 8 weeks 
[36]. In addition, unfiltered coffee was strongly associated with the undesirable changes 
in lipid profile, probably due to inhibitory effects of cafestol on bile acid synthesis [25, 
44]. Overall, these human trials provide limited evidence that coffee and its bioactive 
compounds regulate lipid metabolism. This review will summarize the current proposed 
mechanisms of action of coffee and its bioactive compounds on lipid metabolism (Tables 





















3  Caenorhabditis 
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14 ddY mice (♂) ↓b.w.; ↓TG ↑CPT [12] 
330 mg/kg 




70 High fat diet-fed ICR 
and C57BL/6 mice 
(♂) 
 
↓b.w.; ↓Chol; ↓HDL; 
↓Leptin; ↓TG  





42 High fat diet-fed 
C57BL/6J mice (♂) 
↑Adiponectin; ↓b.w.; 
↓Chol; ↓FFA; ↓Glucose; 
↓LDL; ↓Leptin; ↓TG 
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14-105 High fat diet-fed 
C57BL/6J mice (♂) 
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122; ↓SREBP1c; ↓SCD1; ↑UCP2 
[46] 
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2% diet 63 High fat diet-fed 
C57BL/6 mice (♂) 
↓b.w.; ↓Inflammation; 
↓Insulin; ↓TG 




0.1% water 119 Aged C57BL/6 NCr 
mice (♂) 
↑ATP; ↓FFA; ↑Locomotor 
activity; ↓TG 
↓MTOR; ↑PPARα [49] 






84 High fat diet-fed 
Wistar rats (♂) 
 
↓b.w.; ↓Chol; ↓Insulin; 
↓LDL; ↓TG 
↑LXRα; ↓NPC1L1; ↑PPARα; 
↓PPARγ  
[8, 50] 
a b.w., body weight; p.o., per os. 
b ↓, decrease; ↑, increase; b.w., body weight; Chol, cholesterol; FFA, free fatty acids; TG, triglycerides. 
c ACC, acetyl-CoA carboxylase; ACRP, adipocyte complement-related protein; AMPK, AMP-activated protein kinase; ATGL, adipose triglyceride 
lipase; C/EBP, CCAAT/enhancer binding protein; CPT, carnitine palmitoyl transferase; ECH, enoyl-CoA hydratase; FAR, fatty acid- and retinoid-
binding protein; FAS, fatty acid synthase; FOXO, forkhead box O; HSL, hormone sensitive lipase; LXR, liver X receptor; miR, microRNA; mTOR, 
mammalian target of rapamycin; NPC1L1, NPC1-like intracellular cholesterol transporter 1; PKB, protein kinase B; PPAR, peroxisome proliferator 
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[56] 
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11-14 High fat diet-fed 
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3  Caenorhabditis elegans ↓TG ↓ACC; ↓ACS2; ↑ECH4; 





80 mg/kg b.w. 
(i.p.) 
56 High fat diet -fed 
hamsters (♂) 
↓b.w.; ↓Chol; ↓FFA; 
↓Glucose; ↓HDL; ↓Insulin; 
↓LDL; ↓TG 
↑HL; ↓LPL; ↑PPARα [57] 
0.02% diet 56 High fat diet-fed ICR 
mice (♂) 
↑Adiponectin; ↓b.w.; 
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14 Leprdb/db mice (♂) 
 
↑Adiponectin; ↓b.w.; 
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Sprague–Dawley rats (♂) 
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42-105 High fat diet-fed 
C57BL/6 mice (♂) 
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↓Glucose; ↓Insulin; ↓TG 






42 High fat diet-fed 
Sprague-Dawley rats (♂) 
↓b.w.; ↓Chol; ↓FFA; ↓TG ↓ACC; ↑AMPK; ↑CPT1 [62] 
150 mg/kg 
b.w. (p.o.) 
42 High fat diet-fed ICR 
mice (♂) 
↑Adiponectin; ↓b.w.; 
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↓C/EBPα; ↓FABP4; ↓FAS; 





0.056% diet 43 Goko rats (♂) ↓Bile acid; ↓Chol; ↓FFA; 
↓Glucose; ↓Insulin; ↓TG  
↓FAS  [23] 
50 mg/kg b.w. 
(p.o.) 
30 Alloxan-induced diabetes 
Wistar rats (♂) 
↑b.w.; ↓Chol; ↓Glucose; 
↑HDL; ↓LDL; ↓TG 
↓Intestinal Lipase [64] 
50 mg/kg b.w 
(p.o.) 
112 High fat (or cholesterol) 
diet-fed C57BL/6J mice 
(♂) 
↓b.w.; ↓Chol; ↓Glucose 
↓Insulin; ↓TG 




a b.w., body weight; i.p, intraperitoneal; p.o., per os; s.c., subcutaneous. 
b ↓, decrease; ↑, increase; b.w., body weight; Chol, cholesterol; FFA, free fatty acids; TG, triglycerides. 
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c A1R, adenosine 1 receptor; ACAT, acyl-CoA cholesterol acyltransferase; ACC, acetyl-CoA carboxylase; ACOX, acyl-CoA oxidase; AMPK, 
AMP-activated protein kinase; ATG, autophagy related; ATGL, adipose triglyceride lipase; BECN, beclin; C/EBP, CCAAT/enhancer binding 
protein; cAMP, cyclic AMP; CaMKK, calcium/calmodulin-dependent protein kinase kinase; CD, cluster of differentiation; CPT, carnitine 
palmitoyl transferase; ECH, enoyl-CoA hydratase; FABP, fatty acid-binding protein; FAR, fatty acid- and retinoid-binding protein; FAS, fatty acid 
synthase; FOXO, forkhead box O; FXR, farnesoid X receptor; HADHA, hydroxyacyl-CoA dehydrogenase trifunctional multienzyme complex 
subunit alpha; HL, hepatic lipase; HMGR, HMG-CoA reductase; HSL, hormone sensitive lipase; IRS, insulin receptor substrate; LC, microtubule-
associated protein 1A/1B-light chain; LPL, lipoprotein lipase; LXR, liver X receptor; MGAT, monoacylglycerol acyltransferase; MTOR, 
mammalian target of rapamycin; PPAR, peroxisome proliferator activated receptor; RXR, retinoid X receptor; SREBP, sterol regulatory element-
binding protein;  UCP, uncoupling protein.
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2.4.2 Coffee reduces lipogenesis 
Coffee has shown to have fat-lowering effects in humans, which was associated 
with reduced lipogenesis [2]. Coffee extracts [3, 14, 46, 48], CGA [3, 58–60, 62, 65], 
caffeine [52, 54, 56, 65], trigonelline [23] and cafestol [32] have shown to reduce activity 
of key enzymes for lipogenesis: acetyl-CoA carboxylase (ACC), fatty acid synthase 
(FAS) and/or stearoyl-CoA desaturase (SCD). ACC and FAS are responsible for the first 
two steps of de novo lipogenesis, while SCD for the synthesis of monounsaturated fatty 
acids for fat storage [66]. The enzymatic inhibitory effects of coffee and/or its bioactive 
compounds were in part via regulation of upstream transcription factors for lipogenesis: 
CCAAT/enhancer-binding proteins (C/EBP), peroxisome proliferator-activated receptors 
(PPAR, especially PPARγ), and/or sterol regulatory element-binding proteins (SREBP) 
[3, 13, 14, 22, 32, 46, 50, 52, 56, 61, 63, 65]. These transcription factors are well-known 
to regulate adipogenesis, including lipogenesis [66, 67].  
In addition, coffee reduces lipogenesis by regulating another metabolic pathway, 
AMP-activated protein kinase (AMPK), which inhibits ACC and FAS [59, 66]. In fact, 
coffee, CGA, caffeine and trigonelline were able to activate AMPK [22, 55, 59, 62, 68–
70]. Many factors regulate AMPK activity, including the second messenger cyclic AMP 
(cAMP), which is increased by caffeine [55]. Along with increased cAMP, caffeine and 
CGA activated Ca2+/calmodulin-dependent protein kinase (CaMK), which can 
subsequently regulate the AMPK activation [59, 69, 70].  
Coffee can also activate the forkhead box O (FOXO), involved in the insulin-
signaling pathway known to regulate lipogenesis. GCBE and CGA reduced body fat 
dependent to increased FOXO nuclear translocation, leading to an decreased lipogenesis 
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in Caenorhabditis elegans [3]. These suggest that the fat-lowering effects of coffee by 
inhibition of lipogenesis are potentially from its effects on insulin-mediated pathway via 
FOXO.  
Epigenetic modifications by coffee might contribute to its effects on lipogenesis 
as well; coffee and CGA upregulated miR-122, a microRNA abundant in the liver with 
the inhibition of SREBP, ACC and FAS in murine hepatocytes [46]. Similarly, others 
reported that coffee increased miR-96, a microRNA involved in SREBP expression in 
human intestinal epithelial Caco-2 cells [71, 72]. Therefore, coffee and its bioactive 
compounds may inhibit lipogenesis via epigenetic changes. 
2.4.3 Coffee compounds regulate lipid uptake and transport 
Coffee can regulate the fatty acid translocase (FAT/CD36/SR-B2), a key 
transmembrane protein for lipid uptake and transport [73]. Caffeine, CGA and 
trigonelline have shown to decrease the diet-induced hepatic CD36 overexpression [22, 
52, 60, 61]. CD36 is not only important for the uptake of dietary fatty acids, but also able 
to bind lipoproteins in the liver [74, 75]. Thus, the decreased expression of CD36 by 
coffee compounds is probably related to changes in blood lipid profile, including reduced 
triglycerides, cholesterol and LDL levels [22, 52, 60, 61]. It was further suggested that 
caffeine, CGA and trigonelline regulated CD36 via AMPK- and PPARγ -dependent 
pathways [22, 60, 61, 73, 76].  
Other lipid-binding proteins involved in lipid uptake and transport, such as fatty 
acid-binding proteins (FABP) and fatty acid transporters proteins (FATP), were regulated 
by coffee bioactive components [3, 33, 77, 78]. It is suggested that the decreased lipid 
uptake and transport is related to lipogenesis inhibition; FABP4 (also called aP2), a target 
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for PPARγ, was downregulated by caffeine and kahweol in adipocytes [33, 78]. 
Consistently, a fatty acid- and retinoid-binding protein, FAR-4, was required for GCBE 
and CGA to reduce fat accumulation in C. elegans [3]. However, coffee compounds can 
increase lipid uptake and transport in the muscle driven by fatty acid β-oxidation; 
caffeine increased lipid uptake and transport in muscle tissue by regulating FABP, 
FATP1 and FATP4, partially dependent on mitochondrial CD36 [77]. Taken together, 
coffee bioactive compounds regulate tissue-specific lipid uptake and transport via CD36 
and other lipid-binding proteins.  
2.4.4 Coffee increases fatty acid β-oxidation 
There are many reports of coffee and its bioactive compounds on regulating fatty 
acid β-oxidation [3, 12, 14, 32, 52, 54, 56–58, 60–63, 65]. Coffee, CGA, caffeine and 
cafestol have shown to increase the rate-limiting enzyme for mitochondrial fatty acid β-
oxidation, carnitine palmitoyl transferase (CPT), which transports acyl-CoA from cytosol 
into mitochondria [12, 14, 32, 54, 60–62]. In addition, peroxisomal fatty acid β-oxidation 
was increased by CGA and/or caffeine via regulation of acyl-CoA oxidases (ACOX), the 
first step of the peroxisomal fatty acid β-oxidation [52, 61, 65, 79]. 
It is suggested that coffee regulates fatty acid β-oxidation enzymes by activating 
PPARα in the liver and adipose tissues [14, 50, 56–58, 60, 61, 63]. Moreover, PPARβ/δ, 
involved in the fatty acid β-oxidation in muscle tissue, may play a role in the coffee’s 
effects; caffeine upregulated PPARβ/δ in muscle cells [67, 80]. However, it was reported 
that a coffee extract and CGA did not act as PPAR agonists in kidney CV-1 cells [46]. 
Therefore, the mechanism in which coffee and its bioactive compounds activate PPAR is 
yet to be clear.  
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Other nuclear hormone receptors are reported to be involved in the coffee 
bioactive components’ effects on fatty acid β-oxidation. For instance, CGA has shown to 
increase expression of retinoid X receptor (RXR) and decrease liver X receptor (LXR) 
[60], which share similarities with PPARα [81]. There is evidence that cafestol acts as a 
FXR agonist [26]; FXR is not only involved in cholesterol metabolism, but involved in 
fatty acid β-oxidation [82, 83]. Thus, it is possible that cafestol regulates fatty acid β-
oxidation via FXR [51]. Therefore, it can be considered that coffee has pleiotropic effects 
by regulating transcription factors that potentially impact fatty acid β-oxidation.  
2.4.5 Coffee regulates lipolysis 
Coffee and caffeine consumption increased lipolysis, measured by free fatty acids 
and/or glycerol, peaking after 2-4 hours in humans [84–86]. It was suggested that 
caffeine increases lipolysis in adipose tissue by inhibiting adenosine receptor and 
increasing catecholamine levels via the sympathetic nervous system [15, 53, 87]. The 
lipolytic effects of caffeine are mediated by the increased cAMP levels that activate 
enzymes for lipolysis, especially hormone-sensitive lipases (HSL) [55, 66, 87]. 
Consistently, GCBE, CGA and cafestol upregulated HSL and adipose triglyceride lipases 
(ATGL), both responsible for lipolysis in adipose tissue [14, 32, 88]. However, GCBE, 
not CGA, upregulated HSL expression in C. elegans [3]. Since post-transcriptional 
regulation of these enzymes is important [89], the effects of coffee and its compounds on 
lipases activities will need to be determined to confirm the activities of coffee on 
lipolysis.  
The lipolytic effects of coffee compounds are probably regulated by an additional 
pathway, the mammalian target of rapamycin (mTOR) [90]. mTOR was inhibited by 
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coffee, caffeine, trigonelline and kahweol in vivo or in vitro [22, 34, 49, 54]. 
Consistently, the lipolytic effects of caffeine were related to autophagy-lysosomal 
pathway dependent on AMPK and CaMK, known to cross-talk with mTOR [54, 70]. 
Therefore, the effects of coffee and its compounds on the nutrient-sensing pathways 
mTOR, AMPK and CaMK may contribute to the effects of coffee on lipolysis. 
2.4.6 Coffee reduces lipid digestion 
Coffee and its bioactive compounds may reduce dietary lipid digestion, partially 
due to inhibition of digestive lipase [8, 91, 92]. GCBE inhibits pancreatic lipase activity, 
in which half-maximal inhibitory concentration (IC50) was estimated to be 1.98 mg/mL in 
in vitro digestive simulation [92, 93]. The lipase inhibitory effects of coffee is more likely 
due to CGA than caffeine; IC50 for CGA was 13-287 µM and IC50 for caffeine was > 500 
µM [92]. Trigonelline was also found to inhibit lipase and other digestive enzymes in rats 
[64]. GCBE inhibited pancreatic lipase by decreasing surface area of lipid emulsion and 
increasing lipid droplet size in vitro [93].  
Coffee bioactive compounds can also affect lipid digestion, reducing the function 
or synthesis of bile acids, emulsifying agents that enhance lipid digestion [8, 27]. CGA 
was able to bind bile acids in vitro, suggesting that it reduces the bile acid function for 
lipid digestion [8]. Moreover, cafestol was found to inhibit bile acid synthesis in rodents, 
which potentially changes lipid digestion [26, 27]. Therefore, the inhibition of bile acid 
synthesis and lipase activity by coffee and its bioactive compounds may reduce dietary 




In conclusion, coffee and its bioactive components have shown to regulate lipid 
metabolism. Although there is more evidence for coffee extracts, especially GCBE, CGA 
and caffeine, other, less studied compounds (trigonelline, cafestol and kahweol) have 
shown potential to act on lipid metabolism in vivo and/or in vitro studies. Many questions 
about their mechanisms on lipid metabolism remain to be answered, and perhaps with the 
use of ‘omics’ technologies in humans, we will be able to understand and validate the 






OBJECTIVES OF THE PROJECT 
The long-term goal of this project was to facilitate the development of coffee-
related products that may improve human health. The objective was to investigate the 
role of coffee and its bioactive components on lipid metabolism in Caenorhabditis 
elegans. The central hypothesis was that coffee and/or its bioactive compounds modulate 
lipid metabolism in C. elegans, a microscopic transparent worm that has been used for 
obesity studies and to elucidate pathways on lipid metabolism due to its similarities with 
humans. The rationale of this project was that by understanding the effects of coffee and 
its bioactive components on lipid metabolism in C. elegans, we will be able to propose 
mechanisms to be applied in humans.     
 
Specific aims: 
• Determine the effects of green coffee bean extract (GCBE) and 
chlorogenic acids (CGA) on fat accumulation in C. elegans. This aim was designed to 
test the hypothesis that CGA are responsible for the anti-obesity effects of GCBE and 
their mechanisms on lipid metabolism are similar in C. elegans.  
• Determine the underlying mechanisms of action of cafestol on lipid 
metabolism in C. elegans. The working hypothesis of this aim was that cafestol as an 
farnesoid X receptor (FXR) agonist regulates lipid metabolism in C. elegans. 
• Investigate the potential anti-obesity effects of kahweol in C. elegans. The 
aim was to test the hypothesis that kahweol reduces fat accumulation by modulating 





GREEN COFFEE BEAN EXTRACT AND 5-O-CAFFEOYLQUINIC ACID 
REGULATE FAT METABOLISM IN Caenorhabditis elegans 
4.1 Introduction 
Coffee consumption has been associated with reduced weight gain and body fat 
[36, 94]. This is known to be attributed to coffee polyphenols, such as chlorogenic acids 
found in high concentrations in unroasted coffee, also known as green coffee beans. 
Green coffee bean extract (GCBE) usually consists of 50% chlorogenic acids, which are 
various esters formed between cinnamic acids and quinic acid [95]. Among them, 5-O-
caffeoylquinic acid (5-CQA) is one of the most studied chlorogenic acid esters associated 
with effect of GCBE [95–98].  
GCBE and its main chlorogenic acids have shown potential as natural anti-obesity 
agents. In in vitro studies, GCBE and chlorogenic acids inhibit lipase activity, suggesting 
potential reduction of fat absorption [93]. Others reported that GCBE and chlorogenic 
acids attenuate obesity and insulin resistance in rodent models [61, 99–101]. Human 
studies showed that GCBE reduces body weight and improves blood lipid profile [102, 
103]. However, others reported inconsistent effects of GCBE (with ~70% of chlorogenic 
acids) on fat accumulation or insulin resistance in mice [104]. Although limited, reports 
have suggested that GCBE and chlorogenic acids act on AMP-activated protein kinase 
(AMPK) and lipogenesis pathway [14, 46, 59]. Therefore, identifying the mechanism of 




Caenorhabditis elegans is a multi-organ, microscopic and transparent roundworm, 
mostly known for its use in aging studies, but it is also used for obesity research [105]. C. 
elegans has conserved fat and energy regulatory pathways, and its known-whole genome 
sequence makes this model useful for determining mechanisms by using knockout 
mutants and standard molecular biology techniques [105, 106]. Previously, GCBE and 5-
CQA extended the lifespan of C. elegans [107, 108], however, there is no report 
determining GCBE and 5-CQA’s effects on fat metabolism in this model. Thus, the goal 
of the current study was to investigate the mechanisms of action of GCBE and 
chlorogenic acids on fat metabolism using C. elegans as a model system. GCBE used in 
the current study consists of about 50% chlorogenic acids; thus, 5-CQA was used as a 
representative of chlorogenic acids [98, 109].  
4.2 Materials and methods 
4.2.1 Materials 
GCBE powder, which contained about 50% chlorogenic acids and 2% caffeine, 
was purchased from NuSci Institute & Corp. (Batch No. 201511005, Walnut, CA, USA). 
5-O-caffeoylquinic acid (5-CQA, IUPAC numbering, CAS 327-97-9; named previously 
as chlorogenic acid or 3-O-caffeoylquinic acid, pre-IUPAC numbering; [110, 111]) was 
purchased from Sigma-Aldrich Co. (purity ≥ 95%, St. Louis, MO, USA) or Cayman 
Chemical (purity ≥ 95%, Ann Arbor, MI, USA). The amounts of triglyceride and protein 
were quantified using Infinity™ Triglycerides Reagent and Pierce™ Coomassie Plus 
(Bradford) protein reagent from Fisher Diagnostics and Thermo Fisher Scientific 
(Middletown, VA, USA), respectively. TRIzol and gene expression probes were 
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purchased from Thermo Fisher Scientific (Middletown, VA, USA). 2’-Deoxy-5-
fluorouridine (FUDR) was from TCI America (Portland, OR, USA), carbenicillin was 
from Fisher Bioreagents (Pittsburgh, PA, USA), ampicillin was from Sigma-Aldrich Co. 
(St. Louis, MO, USA), and other chemicals were purchased from Fisher Scientific 
(Pittsburgh, PA, USA). Escherichia coli OP50 and C. elegans strains were obtained from 
Caenorhabditis Genetics Center (University of Minnesota, Minneapolis, MN, USA): N2, 
Bristol (wild-type); CE541 [sbp-1(ep79) III.]; CE548 [sbp-1(ep79) III.; epEx141]; 
GR1307 [daf-16(mgDf50) I.]; RB1515 [far-6(ok1811) IV.]; RB1600 [tub-1(ok1972) II.]; 
RB1667 [tax-6(ok2065) IV.]; RB1716 [nhr-49(ok2165) I.]; RB754 [aak-2(ok524) X.]; 
TJ356 [daf-16p::daf-16a/b::GFP + rol-6(su1006)]. 
4.2.2 C. elegans culture 
Worms were cultured according to established protocols [105, 112]. Worms were 
cultured on nematode growth media (NGM) plates (1.7% agar, 2.5 g/L peptone, 51 mM 
NaCl, 25 mM KPO4 buffer pH 6.0, 5 µg/L cholesterol, 1 mM CaCl2, 1 mM MgSO4) and 
incubated at 25°C, except sbp-1 mutants (20°C), on an incubator (model DT2-MP-47, 
Tritech Research Inc., Los Angeles, CA). To obtain synchronized population of worms, 
eggs were collected using bleach solution [112]. M9 buffer (41 mM Na2HPO4, 15 mM 
KH2PO4, 8.6 mM NaCl, 19 mM NH4Cl) were used to wash the eggs, and then the eggs 
were incubated overnight with S-complete (100 mM NaCl, 5.7 mM K2HPO4, 44 mM 
KH2PO4, 5 µg/L cholesterol, 0.1 M C6H5K3O7 pH 6.0, 3 mM CaCl2, 3 mM MgSO4, 50 
µM disodium EDTA, 2.5 µM FeSO4 •7 H2O, 1 µM MnCl2•4 H2O, 1 µM ZnSO4 •7 H2O, 
0.1 µM CuSO4 •5 H2O). In liquid media, L1 stage worms (~1000 worms/mL) were 
cultured in S-complete with ampicillin (100 μg/mL), carbenicillin (50 μg/mL) and dead 
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E. coli OP50 to prevent degradation of extract and compound by live bacteria. After two 
days, L4 stage/young adult worms were treated with FUDR (0.12 mM) to prevent eggs 
from hatching. Green coffee bean extract (GCBE, 10 or 50 mg/mL) and 5-O-
caffeoylquinic acid (5-CQA, 5.33 or 26.5 mg/mL) were freshly prepared with S-complete 
prior to each experiment, then, sterilized with 0.22 µm syringe filter (Fisherbrand, 
Pittsburgh, PA, USA) prior to use. Finally, GCBE (1 or 5 mg/mL) or 5-CQA (0.53 or 
2.65 mg/mL) was added to media and incubated for 3 days. 
 
4.2.3 Triglyceride quantification 
First, worms were collected and washed thrice with water, then samples were 
homogenized by sonication with 0.05% Tween 20 for 3 min [113]. Infinity™ 
Triglycerides Reagent was used to quantify triglyceride with glycerol as standard. Protein 
levels was determined with Pierce™ Coomassie Plus (Bradford) Protein Reagent with 
bovine serum albumin as standard. Absorbances were determined by SpectraMax i3 
microplate reader and SoftMax Pro 6 (version 6.5) from Molecular Devices (Sunnyvale, 
CA, USA). 
 
4.2.4 Food intake, worms size and locomotive behavior 
Worms were transferred to low-peptone NGM plates with thin layer of live E. coli 
OP50 as previously described [113]. For food intake, pharynx contractions (pumping 
rate) per 30 s of worms were counted using a stereomicroscope. For size and locomotive 
behavior, worms were recorded for 1 min and then average speed [µm/s; (forward 
distance + reverse distance)/time], width (µm), and length (µm) were measured by 
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WormLab tracking system (model MSCOP-002, MBF Bioscience, MicroBrightField 
Inc., Willinston, VT, USA) and WormLab software (3.1.0 64-bit, MBF Bioscience, 
Williston, VT, USA).  
 
4.2.5 Real-time PCR 
Total RNA was isolated using TRIzol following the manufacturer’s protocol 
(Thermo Fisher Scientific, Inc., Middletown, VA). cDNA was generated using high-
capacity cDNA reverse transcription kit (Thermo Fisher Scientific, Inc., Middletown, 
VA) and standard thermal cycler (Bio-Rad Laboratories Inc., Hercules, CA). Relative 
quantitative RT-PCR was carried out using StepOnePlus™ Real-Time PCR system 
(Applied Biosystems, Foster City, CA). Results were analyzed using the comparative 
threshold cycle (Ct) method and expressed as fold change of gene expression (2−∆∆𝐶𝑡 ) 
[114]. TaqMan gene expression assays (Thermo Fisher Scientific, Inc., Middletown, VA) 
used were aak-1 (Ce02406989_g1), aak-2 (Ce02404250_m1), acs-2 (Ce02486193_g1), 
acs-11 (Ce02431951_m1), atgl-1 (Ce02406730_g1), cebp-2 (Ce02421574_g1), daf-16 
(Ce02422838_m1), daf-2 (Ce02444336_m1), ech-4 (Ce02438697_g1), far-6 
(Ce02466862_g1),  fasn-1 (Ce02411648_g1), hosl-1 (Ce02494529_m1), let-363 
(Ce02417512_m1), mdt-15 (Ce02406575_g1), nhr-49 (Ce02412667_m1), pod-2 
(Ce02427721_g1), and ama-1 (Ce02462726_m1, internal control).  
 
4.2.6 Fluorescence imaging and quantification 
Measurement of SBP-1 linked to green fluorescence protein (GFP) expression or 
localization of DAF-16::GFP were performed following protocols previously described 
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[115, 116]. Worms were mounted on a thin layer of half dried 3% agarose in water on 
microscopic glass slides with 10 mM sodium azide, then covered with cover slip. Pictures 
were taken using Nikon Eclipse Ti-U (Nikon Instruments Inc., Melville, NY) and 
fluorescence was measured using NIS-Elements Basic Research software (version 
4.20.01, Nikon Instruments Inc., Melville, NY). Whole body of adult worms were 
selected, and intensity was measured subtracting the intensity of background for SBP-
1::GFP (strain CE548). Worms with DAF-16::GFP (strain TJ356) were visually defined 
as nuclear, intermediate or cytoplasmic depending on localization of transcription factor 
DAF-16 [116].  
 
4.2.7 Proteomic analysis  
Worms samples for proteomic analysis were prepared according to previously 
described method [117]. Samples were enzymatically digested with sequence grade Lys-
C/Trypsin (Promega) using the Barocycler NEP2320 (Nest Group). LC-MS/MS analysis 
was conducted using the nano Eksigent 425 HPLC system (Nano cHiPLC 
200 µm × 0.5 mm ChromXP C18-CL 3 µm 120 Å trap column and Nano cHiPLC 
75 µm × 15 cm ChromXP C18-CL 5 µm 120 Å analytical column) coupled with the 
Triple TOF 5600 plus (Sciex, Framingham, MA). Data was acquired by monitoring 50 
precursor ions at 250 ms/scan. The subsequent output was analyzed using MaxQuant 
computational proteomics platform version 1.5.3.30. MaxQuant settings were as follows: 
initial precursor mass: 0.07 Da; fragment mass tolerance: 0.02; amino-acid minimum 
peptide length: 7; data analysis method: ‘label-free quantification’ (LFQ) checked and 
‘match between runs’ interval set to one minute; randomized fasta databases; protein 
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FDR: 1%; enzymes: Trypsin/P and LysC; maximum missed cleavages: 2; maximum 
modifications per peptide: 3; fixed modifications: iodoethanol (C); and variable 
modifications: acetyl (Protein N-term) and Oxidation (M). The resulting output was 
compared both against a common contaminants database and the C. elegans sequence 
database from Universal Protein Database (UniProt) (retrieved 03-01-2018) [118]. An in-
house script was used to determine LFQ intensity. LFQ values were transformed using a 
log2(x) function. To interpolate missing values, a “zero-fill” value of the lowest intensity 
value (16.3705) was used when a protein was absent (i.e., detected in 0/3 biological 
replicates), and the average treatment value was used when a protein was detected in 2/3 
biological replicates. Proteins detected in 1/3 replicates were not used for subsequent 
analysis.  
 
4.2.8 Statistical Analysis 
Data was analyzed by one-way (Fig. 4.3, 4.4A, 4.7B and Table 4.1) or two-way 
(Fig. 4.1, 4.2 and 4.5D) analysis of variance (ANOVA) followed by Tukey-Kramer 
multiple comparison test with SAS Software (version 9.4, SAS Institute, Cay, NC). 
Localization of DAF-16::GFP (Fig. 4.4C) was analyzed using Chi-Square test. Groups 
were considered statistically different when P < 0.05 compared to the control. For 
proteomic data (Fig. 4.6, 4.7A, 4.7B and Table 4.3), statistical analysis was conducted 
using R environment (www.cran.r-project.org). Proteins with P < 0.05 compared to the 
control (ANOVA followed by Tukey test) were categorized in Table 4.2 by molecular 
function or biological process gene ontology terms, ranked by protein enrichment, using 
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Database for Annotation, Visualization and Integrated Discovery (DAVID) v 6.8 and the 
Universal Protein Database (UniProt) [118]. 
 
4.3 Results  
Wild-type C. elegans were treated with different concentrations of GCBE (1 or 5 
mg/mL) and 5-CQA (0.53 or 2.65 mg/mL) for 3 days from L4 stage/young adults to 
determine whether GCBE and 5-CQA reduce fat accumulation. GCBE at 5 mg/mL and 5-
CQA at 2.65 mg/mL decreased triglyceride content by 29% (P=0.0001) and 23% 
(P=0.0001) compared to the control, respectively (Figure 4.1).  
 
Figure 4.1 Green coffee bean extract (GCBE) and 5-O-caffeoylquinic acid (5-CQA) 
reduced fat accumulation in C. elegans. L4 stage/young adult worms (wild-type) were 
treated with GCBE (1 or 5 mg/mL) or 5-CQA (0.53 or 2.65 mg/mL) for 3 days. 
Triglyceride levels were normalized by protein content. Data are means ± S.E. (n = 9-15, 
collected from three independent experiments). Means with different letters are 




Next, we determined GCBE and 5-CQA’s effects on worms feeding and 
locomotor behavior. Pharynx pumping rate was measured for feeding behavior, and our 
results showed no difference on pumping rates between the treated worms and the control 
group (Table 4.1). Treatments of GCBE and 5-CQA at the tested doses did not change 
locomotor behavior of C. elegans (Table 4.1). GCBE at 1 mg/mL and 5-CQA at 2.65 
mg/mL decreased worm width 11% (P=0.0128) and 8% (P=0.0030) compared to the 
control, respectively, while no difference in worm length was observed after treatment of 
GCBE and 5-CQA (Table 4.1). Decreased width may be reflected in reduced body fat, 
seen in Fig. 4.1, and consistent to previous report [113]. Taken together, these results 
suggest GCBE and 5-CQA’s fat-lowering effects are unlikely to be associated with 
changes on food intake or energy expenditure.  
Table 4.1. Effect of green coffee bean extract (GCBE) and 5-O-caffeoylquinic acid (5-
CQA) on pharynx pumping rate, locomotive behavior and body size of wild-type 
Caenorhabditis elegans. 
Treatment mg/mL Pumping rate 
(contractions/ 30 s) 
Speed (µm/s) Length (µm) Width (µm) 
Control  71 ± 2 41.9 ± 4.1 626.0 ± 10.7  42.5 ± 0.6a 
GCBE  1 69 ± 4 42.2 ± 9.2 629.6 ± 24.0 37.7 ± 1.3b 
5 63 ± 2 39.4 ± 7.9 609.2 ± 20.7 41.4 ± 1.1a 
5-CQA 0.53 65 ± 4 44.5 ± 5.2 618.9 ± 13.7 40.7 ± 0.8a 
 2.65 65 ± 2 44.6 ± 5.2 618.0 ± 13.6 39.2 ± 0.8b 
L4 stage/young adult worms were treated with GCBE or 5-CQA for three days. Worms 
were transferred to a low-peptone NGM plates with E. coli OP50. Number of pharyngeal 
contractions of randomly selected worms was counted for 30 s (n = 10-24). Speed, length 
and width were measured on automatic tracking system (n = 30-116). Data are mean ± 




Next, selected C. elegans mutants were used to determine whether certain genes 
are required for GCBE and 5-CQA’s fat-lowering effects. Sterol regulatory element-
binding protein (SREBP) in mammals is one of major regulators for lipogenesis that is 
conserved in C. elegans as the ortholog, SBP-1 [106]. Our results showed the treatments 
of GCBE and 5-CQA had no effects on fat accumulation in sbp-1 knockdown nematodes 
(Figure 4.2). These results suggested GCBE and 5-CQA’s effects on fat reduction 
requires SBP-1.  
DAF-16, an ortholog of mammalian Forkhead box O (FOXO) transcription factor, 
is part of insulin/insulin-like growth factor receptor signaling (IIS) pathway, which 
regulates energy homeostasis in C. elegans [106]. Although 5-CQA’s fat-lowering effect 
was abolished, GCBE increased fat accumulation by 26% (P=0.0003) compared to the 
control in daf-16 mutants (Fig. 4.2), both of which were different from those in the wild-
type (Fig. 4.1). These results suggest that fat-lowering effects of GCBE and 5-CQA may 
depend on DAF-16 as well.   
NHR-49 in C. elegans is functional ortholog to the mammalian peroxisome 
proliferator-activated receptor α (PPARα), which regulates fatty acid β-oxidation [106]. 
GCBE and 5-CQA’s fat-lowering effects remained in nhr-49 mutant (P=0.0003 and 
P˂0.0001, respectively, Fig. 4.2), suggesting that GCBE and 5-CQA’s fat-lowering 
effects are independent of NHR-49.  
AMP-activated protein kinase (AMPK) is a key player in energy homeostasis, 
acting as a nutrient sensor and also regulating fat metabolism [106]. GCBE and 5-CQA’s 
fat-lowering effects remained in aak-2 mutant (P=0.0154 and P=0.0333, respectively, 
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Fig. 4.2), suggesting that GCBE and 5-CQA’s fat-lowering effects are independent of 
aak-2. 
tub-1, an ortholog of mammalian TUBBY, is known to affect fat accumulation 
and act synergistically with intestinal enzymes responsible for fatty acid β-oxidation 
[106]. Treatment of GCBE and 5-CQA significantly reduced fat accumulation in tub-1 
mutant (P=0.0013 and P=0.0408, respectively, Fig. 4.2). These results suggest GCBE 
and 5-CQA’s fat-lowering effects are independent of tub-1. 
 
Figure 4.2. Effects of green coffee bean extract (GCBE) and 5-O-caffeoylquinic (5-
CQA) on fat accumulation in mutant C. elegans. L4 stage/young adult worms were 
treated with GCBE (5 mg/mL) or 5-CQA (2.65 mg/mL) for 3 days. Triglyceride levels 
were normalized by protein content. Data are means ± S.E. (n = 3-13, collected from 1-4 
independent experiments). Means with different letters at each variable are significantly 
different at P ˂ 0.05. 
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Based on results in Fig. 4.2 that GCBE and 5-CQA’s fat-lowering effects are 
dependent on SBP-1, we further determined the effect of GCBE and 5-CQA on the 
expression levels of sbp-1, and its target genes; acetyl-CoA carboxylase (ACC/pod-2) 
and fatty acid synthase (FAS/fasn-1), which are key enzymes of de novo fatty acid 
synthesis [105]. GCBE and 5-CQA reduced expression of SBP-1::GFP by 14% compared 
to the control (P=0.0149 and P=0.0133, respectively, Fig. 4.3A). GCBE and 5-CQA 
reduced transcript levels of pod-2 significantly by 12% and 24% compared to the control 
(P=0.0053 and P=0.0002, respectively), without any effect on fasn-1 (Fig. 4.3C).  
 
Figure 4.3. Effects of green coffee bean extract (GCBE) and 5-O-caffeoylquinic (5-
CQA) on sbp-1, pod-2 and fasn-1 expression in C. elegans. Worms were treated with 
GCBE (5 mg/mL) or 5-CQA (2.65 mg/mL) for 3 days. A – SBP-1::GFP expression was 
measured using fluorescence microscope (n = 30-40). B – Representative images of SBP-
1::GFP expression. C – Gene expression of pod-2 and fasn-1 using real time-PCR (n = 3). 
Data are means ± S.E. Means with different letters at each variable are significantly 
different at P ˂ 0.05. 
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Based on results in Fig. 4.2 that GCBE and 5-CQA’s fat-lowering effects are 
dependent on DAF-16, we then determined the effect of GCBE and 5-CQA on the 
expression levels of IIS pathway: daf-2 (an ortholog of insulin/insulin-like growth factor 
receptor and an upstream regulator of DAF-16) and daf-16. Although GCBE significantly 
increased transcript levels of daf-2 by 11% (P=0.0158) compared to the control, GCBE 
and 5-CQA did not have any effect on daf-16 (Fig. 4.4A). Since it is known that DAF-16 
can be regulated post-transcriptionally by different environmental conditions, such as 
dietary restriction, effects of GCBE and 5-CQA on nuclear translocation of DAF-16 were 
determined [105, 116]. Our results showed that GCBE and 5-CQA induced nuclear 
translocation of DAF-16::GFP compared to the control (P=0.046 and P=0.024, 
respectively, Fig. 4.4C). These results suggest that effects of GCBE and 5-CQA are 
mediated by post-transcriptional regulation of DAF-16, independent of DAF-2 in C. 
elegans.  
Effects of GCBE and 5-CQA on genes expression that were associated with 
fat/energy metabolism were determined to further evaluate their role in the lipid 
metabolism. cebp-2 (an homolog of CCAAT/enhancer-binding proteins) plays a 
significant role in lipid metabolism in C. elegans [105]. Treatment of 5-CQA, but not 
GCBE, significantly downregulated cebp-2 by 22% (P=0.0052) compared to the control 
(Fig. 4.5).  
Consistent to the observation in Fig. 4.2, GCBE and 5-CQA had no effects on 
AMPK, both aak-1 and aak-2 (Fig. 4.5). let-363, a TOR (target of rapamycin) homolog 
in C. elegans, act as nutrient sensor to regulate growth and metabolism with extensive 
cross talk between AMPK and IIS pathway [106] and also known to be regulated by 
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DAF-16 activity [119]. The results showed that GCBE and 5-CQA did not change let-363 
transcript levels (Fig. 4.5). 
 
 
Figure 4.4. Effects of green coffee bean extract (GCBE) and 5-O-caffeoylquinic (5-CQA) 
on markers of insulin-signaling pathway in C. elegans. L4 stage/young adult worms were 
treated with GCBE (5 mg/mL) or 5-CQA (2.65 mg/mL) for 3 days. A – Gene expression 
of daf-2 (insulin/insulin-like growth factor receptor ortholog) and daf-16 (DAF-16/FOXO 
transcription factor) using real time-PCR (n = 3). B – Representative images of DAF-
16::GFP in worms scored as cytoplasmic (control) and nuclear (GCBE and 5-CQA). C – 
Distribution of DAF-16::GFP (%) scored as cytoplasmic, intermediate or nuclear (n = 60-
80). Data are means ± S.E. Means with different letters at each variable are significantly 
different at P ˂ 0.05. 
 
There are two lipases that are important for lipolysis in C. elegans: atgl-1 (a 
homolog of adipose triglyceride lipase) and hosl-1 (a homolog of hormone-sensitive 
lipase) [105]. Treatments of GCBE and 5-CQA did not affect atgl-1 expression, while 
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GCBE, but not 5-CQA, significantly upregulated hosl-1 by 13% compared to the control 
(P=0.0116) (Fig. 4.5). These suggest GCBE increased lipolysis by HOSL-1, which may 
be independent of effects of chlorogenic acids. 
Mitochondrial acyl-CoA synthetase gene, acs-2, encodes a protein for fatty acid 
β-oxidation, which it is known to be regulated by changes of diet in C. elegans [106, 
120]. GCBE and 5-CQA had distinct effect on acs-2 levels; GCBE upregulated acs-2 by 
49% (P=0.0079), while 5-CQA downregulated acs-2 by 39% (P=0.0209) compared to 
the control (Fig. 4.5), suggesting that GCBE and 5-CQA regulate ACS-2 differently. 
 
Figure 4.5. Effects of green coffee bean extract (GCBE) and 5-O-caffeoylquinic (5-
CQA) on fat/energy metabolism-related genes expression. L4 stage/young adult worms 
were treated with GCBE (5 mg/mL) or 5-CQA (2.65 mg/mL) for 3 days. Data are means 
± S.E. (n = 3). Means with different letters at each variable are significantly different at P 
˂ 0.05. 
 
Nuclear hormone receptor, NHR-49, interacts with mediator subunit MDT-15 
regulating fat metabolism genes, including acs-2 [106]. Treatments of GCBE and 5-CQA 
did not change nhr-49 or mdt-15 expression compared to the control (Fig. 4.5), 
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suggesting that GCBE and 5-CQA act independently of NHR-49 and MDT-15. This is 
consistent with the result in Fig. 4.2 that GCBE and 5-CQA’s fat-lowering effects are 
independent of NHR-49. 
Next, we attempted to identify GCBE and 5-CQA-regulated proteins levels in vivo 
using a shotgun proteomic approach. A total of 63 proteins were identified as 
differentially regulated by GCBE or 5-CQA compared to the control (Table 4.3). Proteins 
were further clustered by molecular function and biological process terms, as listed in 
Table 4.3, which include oxidoreductase activity, aldehyde dehydrogenase, protein 
homeostasis, biosynthesis of amino acids, membrane, metal ion binding, ion transport 





Figure 4.6. Clusters of proteins identified as differentially expressed in GCBE or 5-
CQA-treated wild-type worms compared to the control. L4 stage/young adult worms 
(wild-type) were treated with GCBE (5 mg/mL) or 5-CQA (2.65 mg/mL) for 3 days, 
then proteins identified by shotgun proteomic approach (P < 0.05, n = 3). A – 
Clusters of proteins with common molecular function or biological process terms 
using Database for Annotation, Visualization and Integrated Discovery (DAVID) 




Table 4.2. Protein functional classification and term annotation of proteins differently expressed in green coffee bean extract (GCBE) 
or 5-O-caffeoylquinic acid (5-CQA)-treated C. elegans compared to control. 
Classification Terms Number of non-
redundant 
proteins 
Oxidoreductase activity GO:0055114 - Oxidation-reduction process 
GO:0016491 - Oxidoreductase activity 
UP Keyword - Oxidoreductase 
cel01130 - Biosynthesis of antibiotics 
16 
Aldehyde dehydrogenase cel00330 - Arginine and proline metabolism 
IPR016162 - Aldehyde dehydrogenase, N-terminal 
IPR016161 - Aldehyde/histidinol dehydrogenase 
IPR015590 - Aldehyde dehydrogenase domain 
IPR016163 - Aldehyde dehydrogenase, C-terminal 
GO:0016620 - Oxidoreductase activity, acting on the aldehyde or oxo 
group of donors, NAD or NADP as acceptor 
1 
Protein homeostasis GO:0005839 - Proteasome core complex 
IPR001353 - Proteasome, subunit alpha/beta 
GO:0004298 - Threonine-type endopeptidase activity 
UP Keyword - Threonine protease 
GO:0051603 - Proteolysis involved in cellular protein catabolic  
UP Keyword - Protease 
GO:0000502 - Proteasome complex 
UP Keyword - Proteasome 
GO:0006508 - Proteolysis 
GO:0008233 - Peptidase activity 
cel03050 - Proteasome 




UP Keyword - Nucleus 
GO:0005634 - Nucleus 
GO:0016787 - Hydrolase activity 
Biosynthesis of amino acids cel00280 - Valine, leucine and isoleucine degradation 
cel00410 - beta-Alanine metabolism 
cel00071 - Fatty acid degradation 
cel01130 - Biosynthesis of antibiotics 
1 
Membrane GO:0043231 - Intracellular membrane-bounded organelle 
GO:0016020 - Membrane 
GO:0016021 - Integral component of membrane 
UP Keyword - Membrane 
UP Keyword - Transmembrane helix 
UP Keyword - Transmembrane 
8 
Metal ion binding UP Keyword - Potassium 
UP Keyword - Metal-binding 
GO:0046872 - Metal ion binding 
2 
ATP-binding UP Keyword - ATP-binding 
GO:0005524 - ATP-binding 
UP Keyword - Nucleotide binding 




GO:0000003 - Reproduction 
GO:0002119 - Nematode larval development 
GO:0009792 - Embryo development ending in birth or egg hatching 
8 
Other  15 
Gene Ontology Consortium (GO terms), KEGG pathway (cel terms), InterPro (IPR terms) and UniProt (UP keyword) used to cluster 




Table 4.3. Proteins identified as differentially expressed in green coffee bean extract (GCBE) or 5-O-caffeoylquinic acid (5-CQA)-
treated C. elegans compared to the control.  
   GCBE 5-CQA 


































































































































































































































































































































GCBE increased 25 protein levels and decreased 20 protein levels, while 5-CQA 
increased 20 proteins levels and decreased 8 protein levels, compared to the control (Fig. 
4.6B). Among those proteins, the ones that are potentially associated with fat metabolism 
are enoyl-CoA hydratase (ECH-4, Q09603), fatty acid-CoA synthetase family protein 
(ACS-11, Q20264), fatty acid/retinol binding protein (FAR-6, Q9XUB7) and 
serine/threonine-protein phosphatase 2B catalytic subunit (TAX-6, Q0G819) (Fig. 4.7). 
 
Figure 4.7. Effects of green coffee bean extract (GCBE) and 5-O-caffeoylquinic (5-
CQA) on fat metabolism-associated proteins and genes. L4 stage/young adult worms 
were treated with GCBE (5 mg/mL) or 5-CQA (2.65 mg/mL) for 3 days. A - Fat 
metabolism-associated proteins levels identified as differentially expressed in GCBE or 
5-CQA-treated wild-type worms compared to the control by shotgun proteomic approach. 
Data are fold change compared to the control (n = 3, *P ˂ 0.05, **P ˂ 0.001). B - Effects 
of GCBE and 5-CQA on target proteins-encoding genes expression in wild-type worms. 
Data are means ± S.E. (n = 3). C - Effects of GCBE and 5-CQA on fat accumulation in 
mutant C. elegans of identified proteins. Triglyceride levels were normalized by protein 
content. Data are means ± S.E. (n = 4-8, collected from 1-2 independent experiments). 




Enoyl-CoA hydratase (ECH-4) and fatty acid-CoA synthetase (ACS-11) are 
enzymes involved in fatty acid β-oxidation [120]. GCBE and 5-CQA increased levels of 
enoyl-CoA hydratase (ECH-4) by 56% and 48%, respectively, compared to the control 
(P=0.0234 and 0.0398, respectively) (Fig. 4.7A). GCBE, but not 5-CQA, increased fatty 
acid-CoA synthetase (ACS-11) by 79% compared to the control (P=0.0117) (Fig. 4.7A). 
At transcript levels, GCBE increased ech-4 expression by 9% (P=0.0405), but neither 
GCBE or 5-CQA affects acs-11 expression (Fig. 4.7B). Taken together our proteomics 
and gene expression results suggest GCBE and 5-CQA regulate fatty acid β-oxidation 
through different enzymes, such as ECH-4 and ACS-11. 
Lipid-binding proteins, known as intracellular lipid chaperones, are suggested as a 
target for metabolic diseases treatment [121, 122]. C. elegans contains different types of 
lipid binding proteins; LBPs, homolog of mammals fatty-acid binding proteins (FABPs), 
and FARs, fatty acid and retinoid-binding proteins, which it is structurally unique in C. 
elegans [121]. GCBE decreased levels of FAR-6 by 99% (P˂0.0001) (Fig. 4.7A), which 
was confirmed at transcript levels; GCBE decreased far-6 expression by 37% (P=0.0002) 
(Fig. 4.7B). Consistently, our results showed that GCBE’s fat-lowering effect was 
abolished in far-6 mutants (Fig. 4.7C). Furthermore, our results showed that 5-CQA’s fat-
lowering effects were also abolished in far-6 mutant (Fig. 4.7C), even though 5-CQA did 
not change FAR-6 at translational or transcript levels (Fig. 4.7A & B). These results 
suggest GCBE and 5-CQA require FAR-mediated lipid uptake and transport in C. 
elegans for their effects on reducing fat accumulation, which may be independent of 
transcriptional and translational levels.  
 
 46 
Calcineurin, a serine/threonine phosphatase, has multiple biological functions, 
including fat metabolism [123, 124]. Our proteomics results showed GCBE increased 
calcineurin catalytic subunit (TAX-6) by 19% compared to the control (P=0.0153, Fig. 
4.7A) and 5-CQA decreased TAX-6 levels by 99% compared to the control (Fig. 4.7A). 
However, GCBE and 5-CQA significantly reduced fat accumulation in tax-6 mutant 
(P=0.0044 and P=0.0179, respectively, Fig. 4.7C), which suggests that TAX-6 is not a 
requirement for their effects on fat accumulation in C. elegans.  
 
4.4. Discussion 
Coffee is one of the most consumed beverages in the world and is rich in 
polyphenols [36, 94, 95]. Previous reports suggest that consumption of GCBE, which 
consists of ~50% of chlorogenic acids, could reduce body weight, improve lipid profile 
and insulin sensitivity [59, 93, 96, 99, 101–103]. However, there is limited knowledge 
regarding how GCBE regulates fat accumulation. In the current study, we found that 
GCBE and 5-CQA, one of the main chlorogenic acids, reduce fat accumulation in C. 
elegans dependent on sbp-1 and daf-16, which are involved in lipogenesis and insulin-
signaling pathway, respectively. We identified lipid-binding protein, FAR-6, involved in 
lipid uptake and transport, was identified as a possible target for GCBE and 5-CQA. 
These are consistent to previous reports that chlorogenic acids reduce fat accumulation by 
regulating lipogenesis-related molecules, such as SREBP and ACC [46], and induce 
nuclear translocation of DAF-16 [108]. Therefore, chlorogenic acids are likely to be 
responsible for GCBE effects on fat metabolism. Moreover, our study is the first to show 
GCBE and 5-CQA influence on fatty acid β-oxidation and lipid transport pathways. 
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Similar to the GCBE and 5-CQA’s effects on fat accumulation in C. elegans, 
hesperidin, piceatannol and cranberry phenolic extract reduce fat accumulation via SBP-1 
pathway, regulating its downstream target genes [113, 115, 125]. Also, GCBE and 5-
CQA act via IIS pathway modulating the FOXO transcription factor, DAF-16, similarly 
to other bioactive compounds, such as piceatannol [126]. Although there are similarities 
on mechanism of actions between different compounds, the effective doses of GCBE (5 
mg/mL) and 5-CQA (2.65 mg/mL or 7.5 mM) on fat reduction in C. elegans were higher 
compared to other phenolics compounds and plant extracts [105, 113, 115, 127]. It is not 
currently possible to extrapolate doses from C. elegans to other mammals, therefore the 
significance of the doses used in the study may need to be carefully interpreted for other 
animal models [105]. 
The effects of GCBE on fat metabolism are known to be associated with 
chlorogenic acids, but in the current study there were some inconsistent results between 
GCBE and 5-CQA. Chlorogenic acids vary in concentrations and forms within GCBE 
[95, 97, 98]. Thus, the mixture of chlorogenic acids within GCBE may act in a different 
way to the singular one, 5-CQA, on fat metabolism pathways in C. elegans. In addition to 
chlorogenic acids, GCBE contains caffeine, trigonelline, sucrose, and amino acids [97, 
98], which may contribute to differences between GCBE and 5-CQA. Therefore, it is 
reasonable to speculate that inconsistent results between GCBE and 5-CQA may derive 
from the different composition of the treatments used.  
The current results showed that GCBE and 5-CQA potentiated activity of DAF-16 
via nuclear translocation independent to their effects on daf-2 or calcineurin catalytic 
subunit (TAX-6). IIS pathway includes DAF-2, an ortholog of the mammalian 
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insulin/insulin-like growth factor receptor and DAF-16 as a downstream key regulator for 
its effects on fat metabolism [106]. DAF-2 act to inhibit DAF-16, however, there are 
other independent pathways that can target DAF-16 activity [128]. Thus, the current 
results suggest that GCBE and 5-CQA may change DAF-16 post-transcriptionally via 
different pathways; calcineurin signaling pathway, which inhibits DAF-16 [123], AMPK 
system and TOR signaling pathway [128]. Alternatively, the current results suggest that 
the reason GCBE was able to activate DAF-16, independent of daf-2 and TAX-6, might 
be due to sucrose present in GCBE [124]. Others reported that GCBE and 5-CQA 
activate DAF-16 via AMPK system [59, 108], although the current results do not show 
that GCBE and 5-CQA act on AMPK system. However, we cannot exclude the 
possibility that GCBE and 5-CQA’s fat-lowering effects are dependent on daf-16 by post-
transcriptional regulation of AMPK.  
GCBE and 5-CQA reduced fat accumulation in wild-type worms (Fig. 4.1), but 
we observed that GCBE significantly promoted fat accumulation on daf-16 mutants, 
while 5-CQA alone did not (Fig. 4.2). This may be due to the difference of sugar contents 
between two treatments; GCBE contains about 10% of sucrose [97, 98]. Excess dietary 
sugar leads to increased fat accumulation, which may be independent to DAF-16 [106, 
129]. Thus, sugar within GCBE may be the responsible for the promotion of fat 
accumulation on daf-16 mutant. These results suggest that with activation of DAF-16, 
GCBE and 5-CQA were able to reduce fat accumulation regardless to the presence of 
sugar (~10%). 
GCBE and 5-CQA had different effects on acs-2 expression, which encodes an 
enzyme involved in fatty acid β-oxidation, downstream of NHR-49 [106]. The results in 
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Figures 4.2 & 4.4 suggest that effects of GCBE and 5-CQA on fat accumulation are 
independent of nhr-49, thus it is unlikely that GCBE and 5-CQA modulate acs-2 via 
NHR-49-dependent pathway, rather potentially via SBP-1-dependent pathway [127, 130]. 
In addition, decreased acs-2 expression by 5-CQA should result in reduced fatty acid β-
oxidation, which is not consistent to 5-CQA’s fat-lowering effect. Consistently, it was 
previously reported that proanthocyanins reduce fat accumulation in C. elegans also 
downregulating acs-2, which was suggested to be by compensatory transcriptional 
responses occurred due to fat depletion [127]. In addition to acs-2, other enzymes related 
to fatty acid β-oxidation were modulated by GCBE and/or 5-CQA; enoyl-CoA hydratase 
(ECH-4) and fatty acid-CoA synthetase (ACS-11). Inconsistent effects on fatty acid β-
oxidation by GCBE and 5-CQA may derive from the additional components, such as 
caffeine, present in GCBE, which also needs to be further tested.  
Fatty acid and retinoid-binding proteins (FARs), structurally unique in C. elegans, 
are one type of lipid binding proteins responsible for lipid uptake and transport [121]. 
Our results showed GCBE decreased far-6/FAR-6 levels and its fat-lowering effects was 
abolished on far-6 mutant, while 5-CQA’s fat-lowering effects was also abolished 
without changes on far-6/FAR-6 levels. A different type of lipid binding protein is a 
target for metabolic diseases treatment in humans, which may be functionally similar to 
FARs [121, 122]. The importance of FARs on fat metabolism in C. elegans needs to be 
further studied. Taken together, our results suggest that far-6 is important for the effects 




GCBE and 5-CQA changed proteins levels associated with several biological 
processes, particularly oxidoreductase activity, aldehyde dehydrogenases and protein 
homeostasis in C. elegans. The changes on protein levels may be associated with other 
biological effects, such as GCBE and 5-CQA’s antioxidant activities, which may be 
associated with oxidoreductase proteins [96, 107, 131]. Additional experiments will be 
necessary to confirm GCBE and 5-CQA’s effects on these protein levels in vivo, and also 
to explain the difference on responses between GCBE and 5-CQA treatments.  
 
4.5. Conclusion   
In summary, GCBE and 5-CQA reduce fat accumulation in C. elegans dependent 
on SBP-1 (involved in lipogenesis), DAF-16 (involved in insulin signaling pathway) and 
FAR-6 (involved in lipid uptake and transport). Chlorogenic acids are most likely 
responsible for GCBE’s fat-lowering effects. Furthermore, C. elegans has been proven as 





CAFESTOL INCREASES FAT OXIDATION AND ENERGY EXPENDITURE IN 
Caenorhabditis elegans VIA DAF-12-DEPENDENT PATHWAY 
5.1 Introduction 
Coffee is one of the most consumed beverages in the world and is known to have 
many health benefits including reduced risk of obesity [132]. The anti-obesity effects of 
coffee are mostly associated with its major bioactive compounds, such as caffeine and 
chlorogenic acids [3, 132]. However, coffee diterpenes, such as cafestol, are also reported 
to contribute to the coffee’s fat-lowering effects, which may be independent of its effects 
on circulating lipid levels [26, 30, 32, 33, 133]. In addition to its effects on lipid 
metabolism, cafestol has a potential use for human health due to its anticancer, anti-
inflammatory and anti-diabetes properties [132].  
It is known that cafestol is an agonist of farnesoid X receptor (FXR), bile acid 
receptor that regulates cholesterol homeostasis and other lipid metabolic pathways, 
including fatty acid metabolism [26, 82]. However, little is known about the mechanism 
of action of cafestol on fatty acid metabolism. Caenorhabditis elegans, a multi-organ 
millimetric roundworm, is an animal model used for mechanistic studies of bioactive 
compounds on fatty acid metabolism with the use of various knockout gene mutants 
along with standard biology techniques [105]. C. elegans has fatty acid metabolic 
pathways similar to humans, including the nuclear hormone factor DAF-12 as the 
homolog of FXR [134, 135]. Thus, we hypothesized that cafestol reduces fat 




5.2 Materials and methods 
5.2.1 Materials 
Cafestol was obtained from Chengdu Biopurify Phytochemicals Ltd (purity ≥ 
98%, lot PRF8042041, CAS 469-83-0, PubChem CID 108052, Chengdu, China). 
Chemicals were purchased from Fisher Scientific (Pittsburgh, PA, USA), but the 
following were obtained from elsewhere: 2’-Deoxy-5-fluorouridine (FUDR, TCI 
America, Portland, OR, USA), carbenicillin (Fisher Bioreagents, Pittsburgh, PA, USA) 
and ampicillin (Sigma-Aldrich Co., St. Louis, MO, USA). Reagents and kits for photo-
colorimetric assays and PCR were purchased from manufacturers, as stated in their 
respective methods section. Caenorhabditis Genetics Center (University of Minnesota, 
Minneapolis, MN, USA) provided Escherichia coli OP50 and C. elegans strains: N2, 
Bristol (wild-type); AA86 [daf-12(rh61rh411) X.]; AA120 [daf-12a::GFP + lin-15(+)]; 
CB1370 [daf-2(e1370) III.]; CE541 [sbp-1(ep79) III]; GR1307 [daf-16(mgDf50) I.]; 
RB1600 [tub-1(ok1972) II.]; RB1716 [nhr-49(ok2165) I]; RB754 [aak-2(ok524) X].  
 
5.2.2 C. elegans culture 
Different C. elegans strains were cultured on nematode growth media (NGM) 
plates at 20°C or 15°C (daf-2 mutant) on an incubator (model DT2-MP-47, Tritech 
Research Inc., Los Angeles, CA) as previously described [3, 105]. Adult worms were 
dissolved using bleach solution followed by washing several times with M9 buffer and 
then S-complete to obtain eggs for a synchronized population [105]. L1 stage worms 
(~1000 worms/mL) were fed with live E. coli OP50 in S-complete containing ampicillin 
(100 μg/mL) and carbenicillin (50 μg/mL). We had to include 0.12 mM FUDR to prevent 
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eggs from hatching after worms had reached L4 stage/young adult stage in both control 
and treated-worms, even though FUDR is known to affect worm metabolism [105, 115]. 
Cafestol was diluted in dimethyl sulfoxide (DMSO) at 30 mM stock solution. Adults 
worms were treated with cafestol (30 or 60 µM) or 0.2% DMSO (control), then incubated 
for 2 days.  
 
5.2.3 Triglyceride quantification 
Worms were transferred to centrifuge tubes, then washed thrice with water [115]. 
After sonication in 0.05% Tween® 20, triglyceride quantification was determined using 
Infinity™ Triglycerides Reagent (Fisher Diagnostics, Middletown, VA, USA) with 
glycerol as standard. Quantity of protein from the same sample was determined using 
Pierce™ BCA Protein Assay Kit (Thermo Fisher Scientific, Middletown, VA, USA) with 
bovine serum albumin as standard. Absorbances were measured by using SpectraMax i3 
microplate reader and SoftMax Pro 6 (version 6.5) from Molecular Devices (Sunnyvale, 
CA, USA).  
 
5.2.4 Behavior and body size 
Low-peptone NGM plates were used to assess worm behavior and size as 
previously described [117]. Briefly, feeding behavior was measured by pharynx 
contractions (pumping rate). An automatic tracking system (WormLab, model MSCOP-
002, MBF Bioscience, MicroBrightField Inc., Willinston, VT, USA) was used to record 1 
min video of the multiple worms; then width, length, maximum amplitude and speed 
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[(forward distance + reverse distance)/time] were calculated by WormLab software (3.1.0 
64-bit, MBF Bioscience, Williston, VT, USA).  
 
5.2.5 Reproduction 
Brood size, progeny and hatchability of C. elegans was measured by counting the 
number of eggs and larvae on a bench microscope [117]. Briefly, L4/young adult worms 
were individually transferred to an NGM 12-well plate with E. coli and 60 µM cafestol or 
0.2% DMSO for 2 days. Worms were transferred daily to a new well until no eggs and 
larvae were observed. Hatchability is the ratio of total laid eggs (brood size) to offspring 
larvae (progeny) [117]. 
 
5.2.6 Real-time PCR 
Two-step RT-PCR was performed by using TRIzol® (Thermo Fisher Scientific, 
Inc., Middletown, VA) to extract total RNA from worms samples; then high-capacity 
cDNA reverse transcription kit (Thermo Fisher Scientific, Inc., Middletown, VA) and 
standard thermal cycler (Bio-Rad Laboratories Inc., Hercules, CA) were used to produce 
cDNA templates following the respective manufacturer’s protocols. Gene expression was 
quantified by using StepOnePlus™ Real-Time PCR system (Applied Biosystems, Foster 
City, CA) and TaqMan® gene probes (Thermo Fisher Scientific, Inc., Middletown, VA): 
aak-1 (Ce02406989_g1), aak-2 (Ce02404250_m1), acs-2 (Ce02486193_g1), acs-11 
(Ce02431951_m1), atgl-1 (Ce02406730_g1), cebp-2 (Ce02421574_g1), cpt-5 
(Ce02419317_g1), daf-12 (Ce02500122_g1), daf-16 (Ce02422838_m1), daf-2 
(Ce02444336_m1), ech-1.1 (Ce02485968_g1), ech-4 (Ce02438697_g1), far-6 
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(Ce02466862_g1),  fard-1 (Ce02493083_m1), fasn-1 (Ce02411648_g1), fat-6 
(Ce02465318_g1), fat-7 (Ce02477066_g1), hosl-1 (Ce02494529_m1), kat-1 
(Ce02434540_g1), let-363 (Ce02417512_m1), lrp-1 (Ce02409772_m1), mdt-15 
(Ce02406575_g1), nhr-13 (Ce02471923_m1), nhr-49 (Ce02412667_m1), nhr-80 
(Ce02421189_g1), pod-2 (Ce02427721_g1), sir-2.1 (Ce02459017_g1), tub-1 
(Ce02435686_m1) and an internal control ama-1 (Ce02462726_m1). Comparative 
threshold cycle (Ct) method was used and results were expressed as fold change of gene 
expression (2−∆∆𝐶𝑡).  
 
5.2.7 DAF-12 expression 
DAF-12 linked to green fluorescence protein (DAF-12::GFP) expression was 
measured by a fluorescence imaging technique using the strain AA120 as previously 
described [3]. Paralyzed worms by 10 mM sodium azide were put on microscopic glass 
slides with a 3% agarose pad. A fluorescence microscope, Nikon Eclipse Ti-U, and NIS-
Elements Basic Research software version 4.20.01 (Nikon Instruments Inc., Melville, 
NY) were used to take the pictures and collect data. 
 
5.2.6 Statistical Analysis 
SAS Software (version 9.4, SAS Institute, Cay, NC) was used to analyze data by one-way 
(Fig. 5.2, 5.3, 5.6 and 5.7) or two-way (Fig. 5.1, 5.4 and 5.5) analysis of variance 
(ANOVA) followed by Tukey-Kramer multiple comparison test. Significance of 




5.3. Results  
After 2 days of treatment, cafestol at 30 and 60 µM decreased triglyceride content 
by 12% (P=0.0001) and 20% (P˂0.0001) compared to the control, respectively (Fig. 
5.1), in adult wild-type C. elegans.  
 
Figure 5.1. Cafestol reduced fat accumulation in C. elegans. Adult worms (wild-type) 
were treated with cafestol (30 or 60 µM) for 2 days. Triglyceride levels were normalized 
by protein content. Data are means ± S.E. (n = 11-12, collected from three independent 
experiments). Means with different letters are significantly different at P ˂ 0.05. 
 
Furthermore, 60 µM cafestol decreased body size of worms: width by 5% (P= 
0.0004, Fig. 5.2A) and length by 7% (P<0.0001, Fig. 5.2B) compared to the control, 
which may be reflected by reduced body fat, observed in Fig. 5.1 [113]. Next, to assess 
whether cafestol’s fat-lowering effects were due to changes in feeding behavior, we 
evaluated pharynx pumping rate, as an indicator of food intake, after treatment with 
cafestol [117]. Our results showed the cafestol did not change feeding behavior (Fig. 




Figure 5.2. Cafestol decreased body size but did not change feeding behavior of wild-
type C. elegans. Adult worms were treated with cafestol (30 or 60 µM) for 2 days, then 
transferred to a low-peptone NGM plates with live E. coli OP50. Body size was measured 
by an automatic tracking system (n = 127-177): A – Width; B – Length; C - Number of 
pharyngeal contractions of randomly selected worms was counted for 30 s. Data are mean 
± S.E. (n = 10-24). Means with different letters at each variable are significantly different 
at P ˂ 0.05. 
Since fat reduction may be linked to changes in reproduction, we further 
determined whether cafestol changes the reproductive ability of the worms [136]. 
Cafestol delayed the C. elegans reproduction, during the 2 days of cafestol treatment, but 
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the total number of laid eggs, offspring larvae and hatchability were not changed by 
cafestol compared to the control (Fig. 5.3). 
 
Figure 5.3. The effects of cafestol on the reproduction of C. elegans. A – number of laid 
eggs per worm (brood size). B – number of offspring larvae (progeny). C – hatchability. 
Data are means ± S.E (n = 3-4). Means with different letters at each variable are 
significantly different at P ˂ 0.05. 
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Next, we used C. elegans knockout mutants, involved in lipid and energy 
metabolism, to determine the genetic requirement for cafestol’s fat-lowering effects. As 
cafestol is a known agonist of FXR, we tested whether the fat-lowering effects of cafestol 
are dependent on the FXR homolog in C. elegans, DAF-12 [26, 134, 135]. Cafestol’s fat-
lowering effects were abolished in daf-12 mutant (Fig. 5.4). We further determined the 
effect of cafestol on the expression levels of daf-12 and a DAF-12-target gene, fard-1 
(homolog of the human fatty acyl-CoA reductase-1, involved in biosynthesis of ether 
lipids) [137]. Cafestol at 60 µM upregulated fard-1 (P=0.0069, compared to the control), 
without changes on daf-12 expression (Fig. 5.5A) nor at protein levels, by DAF-12::GFP 
expression (Fig. 5.6). These suggest that the fat-lowering effects of cafestol are mediated 
by post-translational regulation of DAF-12/FXR in C. elegans.  
 
Figure 5.4. Effects of cafestol on fat accumulation in C. elegans knockout mutants. Adult 
worms were treated with cafestol (30 or 60 µM) for 2 days. Triglyceride levels were 
normalized by protein content. Data are means ± S.E. (n = 4-12, from 1-3 independent 





Figure 5.5. Effects of cafestol on lipid metabolism-related genes expression on wild-type 
worms measured by real time-PCR (A-C). Data are means ± S.E. (n=3-11, from 1-3 
independent experiments). Means with different letters at each variable are significantly 




Figure 5.6. The effects of cafestol on DAF-12::GFP expression. Worms were treated 
with cafestol (60 µM) or control (0.2% DMSO) for 2 days, then transferred to microscope 
agarose pad. A – DAF-12::GFP expression was measured using fluorescence microscope. 
Fluorescence intensity unit was collected from the images of the whole worm body. Data 
are means ± S.E (n = 14-22). Means with different letters at each variable are 
significantly different at P ˂ 0.05. B – Illustrative images of DAF-12::GFP expressed in 
cafestol-treated and control worms. 
 
There are several key players that regulate energy homeostasis important for the 
overall fat accumulation [106]. Insulin/insulin-like growth factor signaling (IIS) pathway 
regulates energy homeostasis and its major players in C. elegans are DAF-2, a homolog 
of insulin/insulin-like growth factor receptor, and its downstream target DAF-16, an 
ortholog of mammalian Forkhead box O transcription factor. Cafestol reduced fat 
accumulation in daf-2 and daf-16 mutants by 9% and 11% at 60 µM, respectively, 
compared to their respective control (P=0.0325 and P=0.0003, respectively, Fig. 5.4). 
Consistently, cafestol did not change daf-2 nor daf-16 transcript levels (Fig. 5.5A). These 
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results suggest that fat-lowering effects of cafestol are independent of the IIS pathway 
regulators, daf-2 and daf-16.  
In C. elegans, adenosine monophosphate-activated protein kinase (AMPK), which 
its subunits are encoded by aak-1 and aak-2, regulates cellular energy along with SIR-2.1 
(ortholog of sirtuin 1, a nicotinamide adenine dinucleotide-dependent deacetylase) [106, 
117]. In addition, the target of rapamycin (TOR), encoded by let-363 in C. elegans, has 
extensive cross-talk with AMPK and IIS pathways to regulate energy homeostasis [106]. 
Both 30 and 60 µM cafestol reduced fat accumulation by 9% in aak-2 mutant (P= 0.0132 
and P= 0.0178, respectively, Fig. 5.4), suggesting that cafestol’s fat-lowering effects are 
independent of aak-2, the subunit responsible for the kinase activity of AMPK [117]. 
Also, cafestol did not change aak-1, aak-2, sirt-2.1 nor let-363 transcript levels (Fig. 
5.5A). These results suggest that cafestol reduces fat accumulation independent of 
AMPK, SIR-2.1 or LET-363 pathways.  
TUBBY-like proteins are involved in the development of obesity via neurologic 
control of energy expenditure [138, 139]. The underlying mechanisms of TUBBY 
pathway on lipid metabolism are not yet elucidated, but C. elegans TUB-1, the ortholog 
of mammalian TUBBY, is known to act on fatty β-oxidation synergistically with the 
intestinal 3-ketoacyl-CoA thiolase (KAT-1) [106]. Cafestol did not reduce fat 
accumulation in tub-1 mutant (Fig. 5.4), suggesting that cafestol fat-lowering effects are 
dependent on TUB-1 pathway. Thus, we further determined the effect of cafestol on the 
tub-1 and kat-1 transcripts levels. 60 µM cafestol upregulated expression of tub-1 by 89% 
compared to the control (P= 0.0096, Fig. 5.5A). However, cafestol did not change kat-1 
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transcription (Fig. 5.4A).  Overall, these suggest that cafestol’s fat-lowering effects are 
via TUB-1-dependent pathway, however, independent to its effect on kat-1 in C. elegans.  
CCAAT/enhancer-binding proteins (C/EBPs) are a family of transcription factors 
that regulate adipocyte differentiation [105]. Even though C. elegans lacks adipocytes 
and its fat accumulates mostly in the intestine as body fat, the C. elegans homolog of 
C/EBP, CEBP-2, regulates body fat and lipogenesis [106, 140]. Our results showed that 
cafestol did not change the expression of cebp-2 on wild-type worms (Fig. 5.5B), which 
suggest that cafestol’s fat-lowering effects are independent to cebp-2. 
Lipogenesis is regulated by several key players in C. elegans, including 
transcription factors and enzymes for the conversion of fatty acids into triglycerides [105, 
106]. Sterol regulatory element-binding protein (SREBP) is a natural target for anti-
obesity agent due to its importance for lipogenesis [3, 113, 115]. In C. elegans, SBP-1, 
the SREBP ortholog, has as downstream targets: pod-2 (encodes acetyl-CoA 
carboxylase), fasn-1 (encodes fatty acid synthase homolog) and fatty acid stearoyl-CoA 
desaturases (fat- 6 and fat-7) [106]. Additionally, the nuclear hormone receptors, NHR-80 
and NHR-13, also control fatty acid desaturation [141]. Our results showed 60 µM 
cafestol reduced fat accumulation in sbp-1 mutants by 20% (P=0.0342, Fig. 5.4), 
suggesting that cafestol’s fat-lowering effects are independent of sbp-1. Moreover, 
cafestol did not change the expression of pod-2, fasn-1, fat-6, fat-7, nhr-80 nor nhr-13 on 
wild-type worms (Fig. 5.5B). These results suggest that cafestol’s fat-lowering effects 
may be independent to its effect on lipogenesis.  
In C. elegans, the nuclear hormone NHR-49 is the functional homolog to the 
mammalian peroxisome proliferator-activated receptor α (PPARα), one of the regulators 
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for fatty acid β-oxidation [106, 120, 141]. Other co-factors and several enzymes are 
involved in the fatty acid β-oxidation, such as mdt-15 (encodes a mediator complex that 
interacts with NHR-49 protein), fatty acid-CoA synthetases (acs-2 and acs-11), enoyl-
CoA hydratases (ech-4 and ech-1.1) and carnitine palmitoyl transferase (cpt-5/CPT) [106, 
120]. Our results showed that 60 µM cafestol reduced fat accumulation in nhr-49 mutant 
by 21% (P<0.0001, Fig. 5.4), suggesting that cafestol’s fat-lowering effects are 
independent of nhr-49. Consistently, the expression of nhr-49, mdt-15, acs-2, acs-11, 
ech-4 and cpt-5 were not influenced by cafestol (Fig. 5.5C). However, 60 µM cafestol 
upregulated ech-1.1 expression by 2-fold relative to the control (P=0.0293, Fig. 5.5C). 
Taken together, our results suggest that cafestol regulates fatty acid β-oxidation via ech-
1.1. 
Lipolysis, lipid uptake and transport are also important factors for the overall fat 
accumulation [3, 105]. Several lipases responsible for the triglycerides breakdown are 
found in C. elegans, such as atgl-1 (a homolog of adipose triglyceride lipase) and hosl-1 
(a homolog of hormone-sensitive lipase) [105]. However, cafestol did not influence atgl-
1 or hosl-1 expression (Fig. 5.5B). In C. elegans, lipid-binding proteins, such as fatty acid 
and retinoid-binding proteins (FAR) and low-density lipoproteins (LDL), are involved in 
lipid uptake and transport [3, 142]. Cafestol did not change expressions of far-4 nor lrp-1 
(an LDL receptor-related gene) (Fig. 5.5C). Overall, these results suggest that cafestol 
does not regulate lipolysis or lipid uptake and transport in C. elegans. 
Since the cafestol’s fat-lowering effects were abolished in daf-12 and tub-1 
mutants (Fig. 5.3), we determined whether cafestol regulates the expressions of tub-1, 
ech-1.1 and fard-1 dependent on daf-12 and/or tub-1. As expected, the upregulation of 
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fard-1 by cafestol was abolished in daf-12 mutant. In addition, the effects of cafestol on 
tub-1 and ech-1.1 expressions were abolished in daf-12 mutant (Fig. 5.7A), suggesting 
that cafestol activated tub-1 and ech-1.1 via daf-12. Next, we determined whether tub-1 is 
required for cafestol’s effect on daf-12, fard-1 and ech-1.1 using tub-1 mutant. Although 
no change of daf-12 expression by cafestol was observed, cafestol downregulated fard-1 
expression by 13% (P=0.0321, compared to the control, Fig. 5.7A) without changes on 
ech-1.1 expression in tub-1 mutant. Overall, these results suggest DAF-12 is an upstream 
regulator of tub-1 to regulate ech-1.1 for the cafestol’s fat-lowering effects. 
Locomotor behavior can be assessed as indicative of energy expenditure for the 
overall fat accumulation in C. elegans [117]. We further determined whether cafestol’s 
fat-lowering effects were due to changes on locomotor behavior. Cafestol increased speed 
on wild-type worms by 38% compared to the control (P= 0.0072, Fig. 5.7B). Since TUB-
1 is located in ciliated sensory neurons, involved in the sensory and locomotor behavior 
in C. elegans [143–145], we determined the effects of cafestol on locomotor behavior in 
the mutants of tub-1 as well as daf-12 since results in Fig. 5.7A showed that daf-12 
regulates tub-1 expression. The increased effects of cafestol on speed were abolished in 
tub-1 and daf-12 mutant (Fig. 5.7B). Taken together, these suggest that cafestol increases 
energy expenditure via DAF-12 and TUB-1-dependent pathways in C. elegans. 
 
5.4. Discussion 
Coffee is one of the most consumed beverages in the world and is known to be 
associated with reduced risk of obesity [132]. Phenolic acids, due to their abundance in 
coffee, are mostly suggested to contribute to the fat-lowering effects of coffee [3]. 
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However, diterpenes found in coffee beans, such as cafestol, also were previously 
reported to regulate fatty acid metabolism [26, 32, 33, 133]. In the current study, we 
found that cafestol reduced fat accumulation dependent on daf-12, FXR homolog, and 
tub-1, the ortholog of mammalian TUBBY in C. elegans. Both DAF-12 and TUB-1 were 
found to be involved in the increased energy expenditure and ech-1.1 upregulation by 
cafestol. These results support the potential use of cafestol for metabolic disorders [28, 
30]. 
 
Figure 5.7. Cafestol’s fat-lowering effects are dependent on daf-12 and tub-1. A – 
Effects of cafestol on the target genes expression on daf-12 and tub-1 mutants measured 
by real time-PCR (n=3). B – Effect of cafestol on locomotor behavior of C. elegans. 
Cafestol (60 µM) increased energy expenditure (speed) on wild-type C. elegans (n = 127-
177), but its effects were abolished on tub-1 mutant (n = 157-170) and daf-12 mutant (n = 
78-80). Data are means ± S.E. Means with different letters at each variable are 
significantly different at P ˂ 0.05. 
 
 67 
There are reports that cafestol does not change circulating lipids, including blood 
cholesterol levels [28, 30, 146]. Consistently, our study shows that cafestol did not 
change lrp-1 expression, the LDL receptor-related gene involved in the cholesterol 
transport in C. elegans [147]. However, others reported the increased blood cholesterol 
and/or triglycerides after cafestol treatment in humans and rodents [26, 133]. It was 
suggested that cafestol increased blood cholesterol levels via not only FXR, but also 
another nuclear hormone factor, pregnane X receptor, which is involved in detoxifying 
pathways in a hyperlipidemic mice model [26]. However, the effects of cafestol on 
cholesterol metabolism may be absent in this model since C. elegans requires regular 
cholesterol intake due to lack of cholesterol synthesis and has typically low levels of 
cholesterol [105]. Thus, the current observation along with the fact that C. elegans does 
not synthesize cholesterol, contributed to the discrepancy of cafestol’s effects on 
cholesterol homeostasis between mammals and C. elegans [105, 135]. Moreover, the 
delayed reproduction by cafestol may be related to cholesterol and DAF-12’s effects on 
the germline signaling pathway in C. elegans [134, 136]. The potential effects of cafestol 
on blood lipids and reproduction needs further study. 
In addition to its role in cholesterol metabolism, it is also known FXR agonists have 
potential use for preventing obesity and fatty liver disease by regulating lipid metabolism, 
including lipogenesis, lipolysis and fatty acid β-oxidation [82, 83]. In fact, known FXR 
agonists, ivermectin and epigallocatechin-3-gallate, showed anti-obesity effects in HepG2 
cells and C. elegans [83, 89, 148]. Consistently, DAF-12/FXR activation by the steroid-
derived hormone, Δ7-dafachronic acid, reduces triglyceride levels by increasing lipolysis 
and fatty acid β-oxidation in C. elegans [134]. However, in the current study we only 
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observed cafestol increases fatty acid β-oxidation, particularly via ech-1.1, without any 
effects on lipogenesis or lipolysis, even though the cafestol’s fat-lowering effects was via 
DAF-12-dependent pathway.  
It has been previously reported that FXR potentiates fatty acid β-oxidation via 
PPARα [82]. However, our results failed to support that cafestol activates ech-1.1 
dependent on nhr-49/PPARα. In addition to nhr-49/PPARα, CEBP-2 and TUB-1 are also 
known to modulate fatty acid β-oxidation [106, 140, 149]. The current results show that 
cafestol had no effect on cebp-2, but upregulated tub-1, suggesting that cafestol activates 
daf-12, then tub-1 subsequently improves fatty acid β-oxidation by ech-1.1. However, 
there is no previous knowledge if daf-12 regulates tub-1 followed by ech-1.1. These need 
to be further validated along with the relevance of these observations in humans. In 
addition, we cannot exclude the possibility that cafestol influences additional targets of 
lipid homeostasis, independent of transcriptional levels, to reduce overall fat 
accumulation. 
The current results showed that cafestol downregulated fard-1 in tub-1 mutant, but 
its expression was increased due to daf-12 in the wild-type worm. It is known that ether 
lipids, in which FARD-1/FAR-1 is responsible for their synthesis, regulates fatty acid 
profile by modulating de novo fatty acid synthesis-related genes, including pod-2, fat-6 
and fat-7 [150]. However, their role on overall fat accumulation is still unclear [150]; no 
changes on body fat or triglycerides levels in C. elegans were observed with the reduced 
FARD-1 activity [137, 150], while mulberry leaf polyphenols reduce fat accumulation 
with upregulation of fard-1 via DAF-12 in C. elegans [136]. Based on our results, we 
infer that cafestol regulates the synthesis of ether lipids via FARD-1 in part tub-1-
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dependent mechanism, although how tub-1 regulates fard-1 independent to daf-12 is not 
clear currently.   
The current results suggest that cafestol increases worm speed, an indicator of 
energy expenditure, dependent on daf-12 and tub-1. Both FXR and TUBBY-like proteins 
have previously shown to regulate energy homeostasis [82, 138, 139, 151]. In C. elegans, 
the expression of DAF-12 is not specific to neurons, while TUB-1 is mostly expressed in 
ciliated neurons, involved in locomotor behavior [143–145]. In humans, TUB transcripts 
were found in the adipose tissue as well as in the hypothalamus, neuron region that 
regulates multiple metabolic pathways including energy expenditure [139]. Although 
there was no detection of cafestol in the brain of mice after oral treatment, there are 
reports that FXR pathway modulates neuron activity in the brain via both direct and 
indirect pathways [32, 152]. Other measurements of energy expenditure need to be used 
to further validate the effects of cafestol on energy expenditure, such as mitochondrial 
oxygen consumption and complexes activities. Moreover, other transcription factors, 
such as NHR-8, known to regulate DAF-12 activity, may be involved in the effects of 
cafestol [153]. Therefore, DAF-12/FXR activation by cafestol may increase energy 
expenditure via the neuroendocrine pathway TUB-1 in C. elegans.   
It was reported that cafestol (1.5 mg/day) reduced fat accumulation in high-fat fed 
mice and cafestol (60 mg/day; equivalent to 10-20 cups of unfiltered coffee) altered 
cholesterol metabolism in humans [25, 32]. As filtered coffee contains less cafestol than 
unfiltered coffee, it is not clear whether cafestol’s effects on fatty acid metabolism seen 
in the current study are relevant from a moderate consumption of regular coffee (1.5-3.75 
mg cafestol from daily intake of 2 to 5 cups of 250 mL) [132]. In addition, the current 
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study showed that cafestol at 30 and 60 µM (9.5 and 19 µg/mL, respectively) had shown 
to be effective on reduction of fat accumulation in C. elegans, which are relatively lower 
effective concentrations compared to other bioactive compounds on fat reduction in the 
same model [3, 89, 113, 115]. Compounds may be absorbed via cuticle or pharynx in C. 
elegans, thus, chemical structure and solubility contribute to its effectiveness in this 
model [105]. However, it is still not known how doses from C. elegans would be 
comparable to other mammals, which may be a limitation of using this model currently.  
Other coffee compounds, such as caffeine and chlorogenic acids, have shown to 
reduce fat accumulation, however, with distinct mechanisms on fatty acid metabolism 
compared to that of cafestol [132]. In C. elegans, caffeine’s fat-lowering effects are 
related to changes on feeding and locomotor behavior via neurological pathways, while 
chlorogenic acids regulate fatty acid metabolism via IIS, lipogenesis, and lipid uptake and 
transport pathways [3, 154, 155]. Other coffee diterpene, kahweol, has shown to act on 
fatty acid metabolism via AMPK system [33]. Although there are limited studies on the 
interaction of coffee bioactive compounds on metabolism, a combination of cafestol, 
caffeic acid and trigonelline has shown to reduce plasma insulin and fatty liver in mice 
[30]. Overall, these reports suggest that cafestol is involved in the health effects of coffee, 
and it may further support the benefits of coffee on obesity [132].  
 
5.5. Conclusion   
In summary, we found that cafestol regulates fatty acid metabolism in C. elegans 





KAHWEOL REDUCES FOOD INTAKE OF Caenorhabditis elegans  
6.1 Introduction 
Coffee is one of the most popular drinks in the world and there are many reports 
about its association with reduced risk of obesity, diabetes and metabolic syndrome [1, 
132]. However, there are controversies about the coffee’s effects on health, which may be 
linked to many minor bioactives present in coffee, including kahweol, a diterpene. 
Kahweol is found up to 0.5 mg in a regular cup of coffee from Arabica coffee beans and 
it has anti-cancer, anti-inflammatory and anti-adipogenesis properties in vitro [132, 156]. 
Studies with kahweol-enriched coffee products (i.e. unfiltered coffee and coffee oil) 
showed that kahweol has effects on lipid metabolism in humans [25, 157]. However, little 
is known about kahweol’s effects on lipid metabolism in vivo [33, 158].  
Caenorhabditis elegans, a millimetric transparent worm, has been useful to 
understand the genetic influence on lipid metabolism, since more than 70% of C. elegans 
lipid metabolism-related genes have homologs in humans [159]. This invertebrate model 
allows the study of its feeding behavior, which it is used for the prospective studies of 
anti-obesity food bioactives that may act on food intake [160–162]. The aim of this study 
was to explore the kahweol’s effects on lipid metabolism in C. elegans. 
6.2 Materials and methods 
6.2.1 Materials 
Kahweol was bought from Chengdu Biopurify Phytochemicals Ltd (purity ≥ 98%, 
CAS 6894-43-5, PubChem CID 114778, Chengdu, China). Carbenicillin and ampicillin 
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were purchased from Fisher Bioreagents (Pittsburgh, PA, USA) and Sigma-Aldrich Co. 
(St. Louis, MO, USA), respectively. Other chemicals were purchased from Fisher 
Scientific (Pittsburgh, PA, USA) unless it is otherwise specified in the methods. C. 
elegans stains (N2 wild-type and eat-2(ad1116) II) and Escherichia coli OP50 were 
obtained from Caenorhabditis Genetics Center (University of Minnesota, Minneapolis, 
MN, USA). The following TaqMan® gene expression primers (Thermo Fisher Scientific, 
Inc., Middletown, VA) were used to perform the relative quantitative RT-PCR: ama-1 
(Ce02462726_m1; internal control), atgl-1 (Ce02406730_g1), daf-2 (Ce02444336_m1), 
daf-16 (Ce02422838_m1), ech-1.1 (Ce02485968_g1), hosl-1 (Ce02494529_m1), nhr-49 
(Ce02412667_m1), sbp-1 (Ce02453000_m1) and tub-1 (Ce02435686_m1). 
6.2.2 C. elegans culture 
Worms were cultured on nematode growth media (NGM) plates at 20°C on an 
incubator (model DT2-MP-47, Tritech Research Inc., Los Angeles, CA) until population 
synchronization by bleach solution was performed as previously described [3]. In liquid 
S-complete media, L1 stage worms (~1000 worms) were cultured in a 12-well plate with 
antibiotics (ampicillin and carbenicillin) and dead E. coli OP50 as food source. 120 µM 
2’-deoxy-5-fluorouridine (TCI America, Portland, OR, USA) was put in the media before 
worms reached adulthood to stop laid eggs from hatching, since it inhibits the DNA 
synthesis and cell division [115]. Adult worms were treated with kahweol (30-120 µM in 
DMSO) or 0.2% dimethyl sulfoxide (DMSO; control) and incubated for 2 days. 




After treatment worms were collected in tubes for sonication in 0.05% Tween 20 
before triglycerides and protein assays [3]. Triglyceride content was determined by using 
Infinity™ Triglycerides Reagent (Fisher Diagnostics, Middletown, VA, USA) with 
glycerol as a standard. Then, triglycerides levels were normalized by protein, measured 
by using Bradford reagent (Sigma-Aldrich Co., St. Louis, MO, USA) with bovine serum 
albumin as a standard. Microplate reader and analysis software (SpectraMax i3 and 
SoftMax Pro 6.5, Molecular Devices, Sunnyvale, CA, USA) were used to measure 
absorbances in the colorimetric assays. The triglyceride and protein ratio is widely used 
to represent the total fat in C. elegans, especially for prospective studies with lipophilic 
molecules, such as kahweol [105]. 
6.2.4 Worm tracking 
Worms were placed in low-peptone agar plate, acclimated under camera light for 
20 min, then recorded in video (1 min) by using WormLab tracking system (model 
MSCOP-002, MBF Bioscience, MicroBrightField Inc., Willinston, VT, USA) [117]. 
Videos were analyzed by WormLab software (3.1.0 64-bit, MBF Bioscience, Williston, 
VT, USA) to obtain length, width and moving speed [117]. 
6.2.5 Optical density measurements 
The optical density at 600 nm (OD 600 nm), which measures turbidity in bacteria 
media, was measure in the sample supernatants at day 0 and day 2 as previously 
described [160]. There was no significant absorbance of kahweol in liquid media at 600 
nm, consistently with previous report of kahweol’s highest absorbance at 290 nm [163]. 
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Microplate reader and analysis software (SpectraMax i3 and SoftMax Pro 6.5, Molecular 
Devices, Sunnyvale, CA, USA) were used for these measurements. 
6.2.6 Fluorescent E. coli quantification 
The green fluorescence protein (GFP) expression after worms fed with the strain 
E. coli OP50-GFP was measured by a fluorescence imaging technique [89]. The 
fluorescence microscope Nikon Eclipse Ti-U (Nikon Instruments Inc., Melville, NY) was 
used to take the pictures of immobile nematodes on microscopic glass slides. Next, we 
used the NIS-Elements Basic Research software version 4.20.01 (Nikon Instruments Inc., 
Melville, NY) to collect data, then the fluorescence intensity of selected area (intestine) 
minus the background was represented as relative to the control. 
6.2.7 Pharynx pumping rate  
Pharynx pumping rate, used to estimate food intake, was measured in 30 s by 
using stereomicroscope [115, 160]. Worms were placed in low-peptone plates with live 
E. coli, then pharynx pumping rate of random worms were measured [115]. Alternatively, 
we used serotonin to induce pharynx pumping rate in liquid media without E. coli; after 2 
days treatment, worms were placed in 96-well plates in liquid media with 10 mM 
serotonin before visual observations as previously described [160]. The observations 
started after 20 min of acclimation under stereomicroscope light. The differences on these 
protocols include the media (solid vs. liquid), E. coli, serotonin and kahweol, which was 
included in the liquid media for the serotonin-induced pharynx pumping rate. 
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6.2.8 Gene expression 
Total RNA was extracted from nematode sample by using TRIzol® (Thermo 
Fisher Scientific, Middletown, VA, USA), then RNA samples were reverse-transcribed 
by using by using high-capacity cDNA reverse transcription kit (Thermo Fisher 
Scientific, Inc., Middletown, VA) according with the respective manufacturer’s 
protocols. Gene signal intensity was detected by StepOnePlus™ Real-Time PCR system 
(Applied Biosystems, Foster City, CA), then comparative threshold cycle (Ct) method 
was used to express the results as fold change of gene expression (2−∆∆𝐶𝑡). 
6.2.9 Statistical analysis 
Data was analyzed by mixed one-way analysis of variance followed by Tukey’s 
test with SAS Software (version 9.4, SAS Institute, Cary, NC). Groups were considered 
statistically different when P < 0.05 compared to the control at each variable. 
6.3 Results 
Kahweol at 30, 60 and 120 µM reduced fat accumulation by 7, 14 and 17% 
(P=0.0038, 30 µM; P˂0.0001, 60 and 120 µM), respectively, compared to the control in 
C. elegans (Fig. 6.1). However, there were no effects of kahweol treatment on body 
length, width or moving speed of C. elegans (Fig. 6.2), which suggest that the reduced fat 
accumulation by kahweol is not associated with changes on body size or energy 





Figure 6.1. Kahweol reduced fat accumulation of Caenorhabditis elegans. Worms were 
treated with kahweol for 2 days. Triglyceride levels were normalized by protein content. 
Data are means ± S.E. (n = 6-7). Means with different letters are significantly different at 
P < 0.05. 
 
 
Next, we evaluated the effects of kahweol on food intake by measuring the optical 
density (OD 600 nm) of culture media since it is known that OD values are associated 
with bacteria concentrations [160]. Even though there were no significant differences on 
absorbance at day 0, treatment of kahweol at 60 and 120 µM had increased OD values by 
34% (P=0.0220) and 105% (P<0.0001), respectively, compared to the control at day 2 
(Fig. 6.3A). This indicates that there were more bacteria left on the media on kahweol’s 
group, representing reduced food intake by kahweol-treated nematodes compared to the 
control. We further determined the effects of kahweol at 120 µM on food intake by using 
E. coli::GFP. As shown in Fig. 6.3B, treatment of kahweol significantly reduced 





Figure 6.2. Kahweol did not change body size and moving speed in Caenorhabditis 
elegans. Worms were treated with kahweol for 2 days. Randomly selected worms were 
recorded in 1 min video, then length (A), width (B) and moving speed (C) were analyzed 
(n = 21-24). Data are mean ± S.E. 
 
Pharynx is the organ that pumps E. coli (diet) from the media to inside, thus, the 
measurements of pharynx contractions (pumping rate) is a behavioral assay that 
represents food intake of C. elegans [160, 164]. However, other behaviors may impact 
food intake without changes on pharynx pumping rate [165]. Our results showed that 
pharynx pumping rate of kahweol-treated worms were not different than the control in 
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solid media with E. coli (Fig. 6.3C). However, kahweol reduced pharynx pumping rate by 
27% (P= 0.0013) compared to the control (Fig. 6.3C) with serotonin (10 mM), a 
neurotransmitter that induces pharynx pumping rate in absence of E. coli [160]. These 
results along with results in Fig. 6.3A and 6.3B indicate that kahweol reduced food 
intake, which may be associated with its presence in the media and/or serotonin pathway 
in C. elegans. 
 
Figure 6.3. Kahweol reduced food intake in Caenorhabditis elegans. Worms were 
treated with kahweol for 2 days. A – Optical density at 600 nm of sample supernatant 
after treatment (n=4). B – Worms were fed with E. coli OP50-GFP, then fluorescence 
intensity of worms was measured in the worm intestine (n=17-18). C – Pharynx pumping 
rate was measured in low-peptone agar plates or liquid media with 10 mM serotonin 
(n=20-30 collected from two-three independent experiments). Data are means ± S.E. 




Since the overall fat accumulation is regulated by lipid metabolism, next we tested 
whether kahweol regulates lipid metabolism-related gene expressions. SBP-1, the 
homolog of the human sterol regulatory element-binding proteins (SREBPs), positively 
regulates fat accumulation via lipogenesis in C. elegans. Kahweol did not regulate sbp-1 
expression in C. elegans (Fig. 6.4).  
NHR-49, a homolog of the human peroxisome proliferator-activated receptor alpha 
(PPARα), regulates fat accumulation negatively by inducing fatty acid β-oxidation in C. 
elegans. Kahweol did not regulate nhr-49 expression in C. elegans (Fig. 6.4), which 
suggest that nhr-49 is not involved in the kahweol’s effects on fat accumulation.  
TUB-1, the homolog of the human tubby proteins (TUB), regulates fat 
accumulation negatively by inducing fatty acid β-oxidation via the enoyl-CoA hydratase, 
ech-1.1, in C. elegans. Kahweol downregulated tub-1 expression by 31% (P=0.0449) and 
ech-1.1 expression by 47% (P=0.0043) compared to the respective controls (Fig. 6.4), 
which suggest that the effects of kahweol on tub-1 and ech-1.1 may contribute for the 
reduced fat accumulation in C. elegans.   
The lipases encoded by atgl-1 (the homolog of the human adipose triglyceride 
lipase, ATGL) and hosl-1 (the homolog of the human hormone-sensitive lipase, HSL) are 
involved in lipolysis in C. elegans. Kahweol downregulated atgl-1 expression by 26% 
(P=0.0377) compared to the control, while hosl-1 expression was not changed by 
kahweol in C. elegans (Fig. 6.4). These results suggest that atgl-1 downregulation may be 
a indicative of the overall reduced fat accumulation by kahweol in C. elegans [89].  
The insulin/insulin-like growth factor signaling (IIS) pathway regulates lipid 
metabolism via daf-2 (the homolog of the human insulin/insulin-like growth factor 
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receptor) and the transcription factor daf-16 (the homolog of the human Forkhead box O 
transcription factor) in C. elegans. Kahweol at 120 µM downregulated daf-2 expressions 
by 35% (P=0.0019) compared to the control in C. elegans (Fig. 6.4). Kahweol, only at 60 
µM, downregulated daf-16 expression by 17% (P=0.0292) compared to the control in C. 
elegans (Fig. 6.4). Overall, these suggest that the kahweol has inhibitory effects on IIS 
pathway, which may contribute for the reduced fat accumulation in C. elegans. 
Figure 6.4. Effects of kahweol on genes related to lipid metabolism in Caenorhabditis 
elegans. Worms were treated with kahweol for 2 days. Data are means ± S.E. (n = 4). 
Means with different letters are significantly different at P ˂ 0.05 at each variable. 
 
eat-2, which encodes an acetylcholine receptor subunit in pharyngeal muscle cells, 
starts the action potential in the pharynx muscle cells, thus eat-2 mutant has reduced food 
intake due to disrupted pharynx contractions [164]. We determined if kahweol’s effects 
on fat accumulation were dependent on the reduced food intake by using eat-2 mutant, 
known to have a reduced pharynx pumping rate [164]. Kahweol did not reduce fat 
accumulation in eat-2 mutant (Fig. 6.5A), which suggests that kahweol’s effects on fat 
accumulation are dependent on food intake. 
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To evaluate whether kahweol regulates the lipid metabolism-related target genes 
(tub-1, ech-1.1, atgl-1, daf-2 and daf-16) dependently on reduced food intake, kahweol’s 
effects on the gene expressions were measured in eat-2 mutant. The expression of tub-1 
was upregulated by 208% (P=0.0110) in eat-2 mutant when compared to the wild-type 
worms (Fig. 6.5), which suggest that the reduced food intake enhances TUB-1 activity. 
However, kahweol’s effects on tub-1 in eat-2 mutant were different than that of wild 
type; kahweol upregulated tub-1 by 44% (P=0.0406) in eat-2 mutant (Fig. 6.5). The 
expression of ech-1.1 was downregulated by 56% (P= 0.0006) in eat-2 mutant compared 
to wild-type worms (Fig. 6.5), which it is consistent with the effects of fasting on ech-1.1 
in C. elegans [120]. Not surprisingly, kahweol’s effect on ech-1.1 seen in wild-type was 
abolished in eat-2 mutant (Fig. 6.5), since ech-1.1 is downstream of TUB-1. Taken 
together, these results suggest that the kahweol’s effects on tub-1 and ech-1.1 are related 
to a reduced food intake, but the tub-1 upregulation by kahweol in eat-2 mutant needs 
further studies. 
 
Figure 6.5. The reduced fat accumulation by kahweol is dependent on reduced food 
intake in Caenorhabditis elegans. eat-2 mutant, which has a reduced food intake due to 
disrupted pharynx function, were treated with kahweol for 2 days.  A – Kahweol’s effects 
on fat accumulation were abolished in eat-2 mutant. Triglyceride levels were normalized 
by protein content. (n = 4). B – The effects of kahweol on genes related to lipid 
metabolism were dependent on food intake in eat-2 mutant (n = 3). Results in B were 
expressed as relative to the wild-type worm control (1.0, indicated with a trace line). Data 
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are means ± S.E. Means with different letters are significantly different at P ˂ 0.05 at 
each variable. 
 
eat-2 mutant is known to have reduced fat accumulation as expected by reduced 
food intake and showed higher atgl-1 expression with a 65% increase (P=0.0022) 
compared to the wild-type worms (Fig. 6.5), suggesting that lipolysis via atgl-1 is 
enhanced by a reduced food intake similarly to fasting [166]. On the other hand, the atgl-
1 downregulation by kahweol seen in wild-type was abolished in eat-2 mutant (Fig. 6.5), 
which suggest that reduced atgl-1 by kahweol treatment seen in wild-type was dependent 
to reduced food intake.  
IIS pathway seemed to be enhanced in response to the reduced food intake in eat-2 
mutants, since daf-2 expression was upregulated by 144% (P<0.0001) in eat-2 mutant 
compared to wild-type worms (Fig. 6.5). However, the expression of daf-16 was not 
changed in eat-2 mutant when compared to wild-type worms (Fig. 6.5), which suggest 
that DAF-16 post-translational changes are more important for the response to a reduced 
food intake [106, 167]. Kahweol did not regulate daf-2 neither daf-16 expressions in eat-
2 mutant (Fig. 6.5). These results suggest that kahweol’s inhibitory effects on IIS 
pathway are dependent on food intake, consistent with the role of IIS pathway as nutrient 
sensor [168]. 
6.4 Discussion 
 Kahweol is a coffee diterpene, found mainly in Arabica coffee beans, that has 
potential biological effects, such as antioxidant, anti-inflammatory, anti-cancer and anti-
obesity properties [132, 156]. The previous studies have shown that kahweol reduces 
adipogenesis in vitro, but there are still limited evidence about kahweol’s effects on lipid 
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metabolism in vivo [33, 158]. In the current study, we showed that kahweol reduced fat 
accumulation dependent on reduced food intake in C. elegans by leading the 
downregulation of lipid metabolism-related genes involved in β-oxidation (tub-1 and ech-
1.1), insulin signaling (daf-2 and daf-16) and lipolysis (atgl-1).  
Appetite suppressors regulate the neurological control of hunger via distinct 
mechanisms; for example, lorcaserin and nicotine act on serotonin and acetylcholine 
pathway, respectively [169, 170]. The feeding behavior of C. elegans is also regulated by 
multiple neurological pathways that control the organ responsible for the food intake, 
pharynx [164]. The reduced pharynx pumping rate by kahweol was limited to serotonin-
induced pharynx contractions suggesting that kahweol acts on serotonin pathway. SER-7, 
the human 5-hydroxytryptamine receptor 7 homolog, is responsible for the pharynx 
contractions in response to exogenous serotonin [160, 171, 172], thus, it is possible that 
kahweol reduces pharynx pumping rate dependent on ser-7. The direct effects of kahweol 
on ser-7 and other pathways (e.g. acetylcholine, glutamate and dopamine) need further 
investigation since they may also contribute for the reduced food intake and/or fat 
accumulation in C. elegans [173–175]. 
It is known that motor neurons are activated by serotonin prior to acetylcholine 
release into the pharyngeal neuromuscular junction, then EAT-2, an acetylcholine 
receptor, together with ionic channels trigger the pharynx contractions in C. elegans [164, 
170, 176–178]. Reports suggest that nicotine, an acetylcholine receptor agonist, at high 
concentrations reduces food intake by reducing pharynx pumping rate whether the 
contractions are induced by E. coli or serotonin in C. elegans [170, 177]. Even though 
kahweol’s effects on lipid metabolism were dependent on eat-2, we cannot rule out that 
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kahweol may reduce pharynx pumping rate due to other neurological pathway that 
controls food intake. 
 It is believed that Tubby proteins, expressed in the human brain and adipose 
tissue, are involved in a neuroendocrine pathway that regulates fatty acid β-oxidation [51, 
139]. However, the effects of TUB-1 on fat accumulation are inconsistent; a gallotannin 
reduced fat accumulation via TUB-dependent pathway, but the effects of the gallotannin 
on tub-1 expression were dependent on diet (i.e. glucose) [179]. The interpretation of the 
effects of kahweol on tub-1 remain still elusive, even though it is unlikely that the 
kahweol’s fat-lowering effects are due to increased β-oxidation. In addition to ech-1.1, 
other TUB-1 targets, as the 3-ketoacyl-CoA thiolase kat-1, may be contribute for the 
effects of kahweol on lipid metabolism in C. elegans [51, 125]. Moreover, the kahweol’s 
effects on TUB-1 and serotonin may be linked, since it was previously reported that 
serotonin reduced lysosome-related fat content via TUB-1 pathway in C. elegans [180, 
181]. Therefore, further studies on how the reduced food intake by kahweol may involve 
TUB-1 pathway are needed. 
It is known that IIS pathway is activated when nutrients are abundant, which leads 
to insulin-like peptides to bind the insulin receptor that triggers a cascade of reactions that 
regulate multiple pathways, including lipid metabolism [105, 106]. The expression of the 
insulin receptor DAF-2 is reduced when worms are starved, which corroborates with the 
daf-2 downregulation by kahweol dependent on food intake [168]. Our results suggest 
that reduced food intake by kahweol may have little or null effects on the DAF-2 
downstream target daf-16 at transcript level, since kahweol, only at 60µM, 
downregulated daf-16 and daf-16 was not regulated in eat-2 mutant. It is known that IIS 
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pathway regulates its downstream DAF-16 by post-translational changes; IIS inhibition 
induces DAF-16 nuclear translocation and subsequently DAF-16 can regulate its 
downstream targets [3, 106, 182]. Although it is still not known if kahweol induce DAF-
16 nuclear translocation, kahweol’s effects on DAF-16 may be similar to other coffee 
bioactives (i.e. caffeine and chlorogenic acid), which was also found to induce DAF-16 
nuclear translocation in C. elegans [3, 183]. 
A reduced fat accumulation may be caused by an increased lipolysis via ATGL-1, 
but ATGL-1 can also represent increased lipogenesis [89, 166, 184–186]. It was 
previously reported that atgl-1 deletion reduced fat accumulation by inhibiting 
peroxisome proliferator-activated receptor gamma (PPAR) and SREBP in addition to a 
reduced food intake in mice fed a high-fat diet [185]. Although the current study showed 
the kahweol does not change sbp-1, other lipogenesis-related factors may influence atgl-1 
in C. elegans [166, 185]. Moreover, it is known that ATGl-1 is regulated by serotonin 
and IIS pathways in C. elegans [166, 174, 175].  The influence of other pathways on 
kahweol’s effects on atgl-1 is to be determined by further studies.   
 
6.5 Conclusion 
In conclusion, kahweol acts as appetite suppressor to reduce fat accumulation in 
C. elegans. Lipid metabolism was regulated by kahweol dependently on food intake, 
which may be due to an effect of kahweol on serotonin pathway. These results suggest 









Coffee drinks are popular around the world, but there are limited studies on the 
effects of coffee and its bioactives on lipid metabolism, including that how coffee 
consumption is associated with lower risk of metabolic syndrome, obesity and diabetes, 
which are conditions with altered lipid metabolism. This dissertation demonstrated the 
effects of green coffee bean extract and coffee bioactives (chlorogenic acid, cafestol and 
kahweol) on lipid metabolism in C. elegans, as an in vivo model. GCBE and the 
chlorogenic acid (5-O-caffeoylquinic acid) had similar effects on lipid metabolism 
dependent on sbp-1, daf-16 and far-6, which are involved in lipogenesis, insulin-
signaling pathway and lipid transport, respectively. However, the coffee diterpene 
cafestol regulated fatty acid β-oxidation and energy expenditure dependent on the 
farnesoid X receptor homolog daf-12, while another coffee diterpene, kahweol, reduced 
fat accumulation dependent on food intake in C. elegans.  
C. elegans can be used further to evaluate other metabolic pathways impacted by 
coffee bioactives. This dissertation focused on coffee’s effects on lipid metabolism, but it 
is possible to elucidate the mechanisms of action and the impact of coffee on lifespan, or 
even host-bacteria interactions by using C. elegans as well. Some of the targets for 
coffee’s fat-lowering effects elucidated in this dissertation, such as DAF-16 and DAF-12, 
may be related to its effects on lifespan, which may be independent of its effects on lipid 
metabolism, for example. Not only the evidence that coffee bioactives can modulate 
DAF-12, but also knowing that DAF-12 is regulated by bacteria show that further studies 
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in C. elegans may help us to understand the mechanisms of potential effects of coffee on 
host-bacteria interactions. 
Coffee research has been focused on its main components, such as caffeine, but 
here it is showed that other coffee bioactives may also be important to be investigated. 
The variability and complexity of coffee composition still need to be explored, especially 
for other coffee-related products, such as extracts or oil, that may be included widely in 
our diet in the future. The expansion on the knowledge of coffee composition, which is 
highly dependent on species, environment, and processing, may help us to find new 
bioactives. Thus, future studies about coffee may need to consider other coffee bioactives 
that may have impact on human health in addition to caffeine.  
Metabolic and high-throughput sequencing analysis, such as shotgun proteomics 
or RNA sequencing, may help to find other targets for coffee bioactives on metabolism. 
With the incorporation of these technologies, maybe we can also understand how coffee 
impacts metabolic pathways, including lipid metabolism, via non-coding RNAs for 
example. Although these tools have now some limitations to be applied in large scale, 
especially in humans, the availability of data provided by these -omics technologies 
would be useful to understand the effects of coffee on metabolism and find potential 
other targets. Thus, we can incorporate these tools in animal studies to suggest 
mechanisms of action of coffee bioactives for further consideration and validation in 
human studies in the future. 
This dissertation corroborates with the fact that coffee has a potential to be used to 
improve human health, including metabolic syndrome, obesity, and diabetes. Although 
the current results are limited in a model system of C. elegans, the underlying 
 
 88 
mechanisms of coffee bioactives on lipid metabolism may be applied in further animal 
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